var title_f32_23_33136="Methoxsalen: Drug information";
var content_f32_23_33136=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Methoxsalen: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/59/37813?source=see_link\">",
"       Methoxsalen (systemic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/19/21811?source=see_link\">",
"       Methoxsalen (topical): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9631 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-07C1274D5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33136=[""].join("\n");
var outline_f32_23_33136=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/59/37813?source=related_link\">",
"      Methoxsalen (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?21/19/21811?source=related_link\">",
"      Methoxsalen (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_23_33137="Four cuff segmental pressures";
var content_f32_23_33137=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F80197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F80197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Four cuff segmental pressures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cuffs are placed on the high thigh, low thigh, below the knee and at the ankle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the Division of Vascular Surgery at OHSU.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33137=[""].join("\n");
var outline_f32_23_33137=null;
var title_f32_23_33138="Measles lesions on face";
var content_f32_23_33138=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Measles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous macules are present on the face and trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33138=[""].join("\n");
var outline_f32_23_33138=null;
var title_f32_23_33139="LGPUC";
var content_f32_23_33139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F76012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F76012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 621px\">",
"   <div class=\"ttl\">",
"    Non-invasive low-grade papillary urothelial carcinoma (LGPUC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 601px; height: 161px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    At low power (A, 20x) LGPUC papillary fronds show frequent branching and minimal fusion. At higher power (B-C, 40x) the urothelial cells maintain an overall orderly appearance with easily recognizable variations in cytologic features. The nuclei are enlarged; mild differences in shape, contour, and chromatin distribution are noted.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33139=[""].join("\n");
var outline_f32_23_33139=null;
var title_f32_23_33140="Cyclobenzaprine: Patient drug information";
var content_f32_23_33140=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cyclobenzaprine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/60/13254?source=see_link\">",
"     see \"Cyclobenzaprine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/5/26709?source=see_link\">",
"     see \"Cyclobenzaprine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F155276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Amrix&reg;;",
"     </li>",
"     <li>",
"      Fexmid&reg; [DSC];",
"     </li>",
"     <li>",
"      Flexeril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F155277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Cyclobenzaprine&reg;;",
"     </li>",
"     <li>",
"      Auro-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      Ava-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      Dom-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      JAMP-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      Mylan-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      Novo-Cycloprine;",
"     </li>",
"     <li>",
"      Nu-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      PHL-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      PMS-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      Q-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      ratio-Cyclobenzaprine;",
"     </li>",
"     <li>",
"      Riva-Cycloprine;",
"     </li>",
"     <li>",
"      ZYM-Cyclobenzaprine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10011230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701871",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cyclobenzaprine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703550",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: A fast heartbeat, an overactive thyroid gland, a recent heart attack, a weak heart, or a slow heartbeat without a working pacemaker.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695770",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take long-acting products at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with rest, PT (physical therapy), pain drugs, and other therapies.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12345 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-961E418322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33140=[""].join("\n");
var outline_f32_23_33140=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155276\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155277\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011230\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011232\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011231\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011236\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011237\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011239\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011234\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011235\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011240\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011241\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?12/60/13254?source=related_link\">",
"      Cyclobenzaprine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/5/26709?source=related_link\">",
"      Cyclobenzaprine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_23_33141="Prenatal diagnosis of talipes equinovarus (clubfoot)";
var content_f32_23_33141=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prenatal diagnosis of talipes equinovarus (clubfoot)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Urania Magriples, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33141/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/23/33141/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clubfoot, or talipes equinovarus, refers to a developmental deformity of the foot in which one or both feet are excessively plantar flexed, with the forefoot swung medially and the sole facing inward (",
"    <a class=\"graphic graphic_picture graphicRef63390 \" href=\"mobipreview.htm?6/44/6850\">",
"     picture 1",
"    </a>",
"    ). It is a common congenital malformation, typically discovered at the time of birth as an isolated anomaly in an otherwise normal neonate.",
"   </p>",
"   <p>",
"    Clubfoot can be classified as congenital, syndromic, or positional. The congenital foot deformity affects the bones, muscles, tendons, and blood vessels of one or both feet. Syndromic cases are associated with additional anatomic malformations",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chromosomal or genetic abnormalities. A positional clubfoot results from the baby's position in the uterus, and is often associated with a restrictive uterine environment (oligohydramnios, uterine anomalies). A positional clubfoot is flexible, rather than rigid, and can be positioned into a neutral position easily by hand.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE AND EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of clubfoot is 1 to 3 per 1000 live births in Caucasians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/1\">",
"     1",
"    </a>",
"    ]. Male fetuses are predominately affected, with a 2-to-1 male to female ratio. The birth prevalence varies among different ethnic groups; the highest rates are seen in individuals of Polynesian ancestry (7 per 1000 live births) and the lowest in Asian populations (0.57 per 1000 live births) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/2\">",
"     2",
"    </a>",
"    ]. Clubfoot is bilateral in 30 to 60 percent of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EMBRYOLOGY OF FOOT DEVELOPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The foot sequentially assumes three different positions during embryonic and early fetal life: at the 15-mm stage (about 8 weeks of gestation), the foot is in a straight line with the leg; by the 30-mm stage (about 10 weeks of gestation), the foot rotates to a marked equinovarus-adductus position; and then by the 50-mm stage (about 11.5 weeks), it changes to a slightly equinovarus adductus position, which remains throughout fetal life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. These positional changes result from the growth of the distal ends of the fibula and the skeletal elements of the lateral foot during the \"fibular phase\" of rapid growth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ANATOMY OF CLUBFOOT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main anatomic abnormality is a mild to severe deformity of the talus, which is small and abnormal in all of its relationships. There is subluxation of the talo-calcaneo-navicular joint with under-development of the soft tissues on the medial side of the foot, and frequently of the calf and perineal muscles. Shortening and fibrosis in the gastrocsoleus and its tendon, as well as in the posterior tibial muscle and tendon, also occur. The ligaments of the forefoot are normal, but the forefoot is adducted and supinated. Bony malposition and secondary contractures cause the foot to be held in a relatively fixed position, which is resistant to realignment. The clubfoot, calf, and leg are smaller and shorter than the normal limb.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases are idiopathic (80 percent) or isolated, with the remainder associated with additional structural and chromosomal or genetic anomalies (",
"    <a class=\"graphic graphic_table graphicRef78890 \" href=\"mobipreview.htm?40/20/41292\">",
"     table 1",
"    </a>",
"    ). Clubfoot, and other types of joint contracture, can be secondary to factors intrinsic or extrinsic to the fetus. Depending upon the etiology, the prognosis varies widely.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrinsic causes &mdash; Fetal abnormalities from intrinsic etiologies tend to be symmetric (eg, bilateral clubfoot) and associated with multiple other findings. Intrinsic causes of clubfoot may reflect early fetal onset of neurologic, muscular, or connective tissue disease with long-term implications for the neonate, as well as for its siblings, especially if an underlying genetic disorder is identified. Most such cases are multifactorial, but pedigrees with Mendelian inheritance have been described (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Recurrence risk'",
"      </a>",
"      below). The sibling of an affected dizygotic twin has a 2-fold increased risk of being affected, while the risk in a monozygotic twin is 10-fold higher [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/5\">",
"       5",
"      </a>",
"      ]. Spina bifida is the most common intrinsic cause of clubfoot.",
"     </li>",
"     <li>",
"      Extrinsic causes &mdash; Extrinsic causes of clubfoot are related to factors external to the fetus that impede the normal sequential growth and position of the foot. The resulting deformation can be secondary to restriction to movement from multiple gestations, malpresentation, uterine cavity abnormalities (eg, fibroids, synechiae, amniotic bands), breech position, or oligohydramnios. Abnormalities tend to be asymmetric, and are not necessarily isolated, particularly if the cause is long-standing. These infants may be born with other \"packaging\" problems such as developmental dysplasia of the hip since this condition may also be related to abnormal positioning",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      limited fetal mobility.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major risk factors for clubfoot are a family history of the defect and the presence of a condition that restricts fetal foot movement, such as crowding in a multiple gestation, oligohydramnios, uterine abnormality, and fetal neuromuscular disorders. These risk factors are generally not modifiable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal diagnosis of clubfoot was first reported in 1985 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/6\">",
"     6",
"    </a>",
"    ]. Transvaginal ultrasound can detect the abnormality as early as 12 to 13 weeks of gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. The sonographic diagnosis is based upon visualization of the plantar surface of the fetal foot in the same sagittal plane as both lower extremity bones (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52044 \" href=\"mobipreview.htm?36/43/37553\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79257 graphicRef59703 graphicRef72507 \" href=\"mobipreview.htm?35/18/36136\">",
"     image 2A-C",
"    </a>",
"    ). The abnormal position should persist over time and despite motion of the foot, since a fetus can temporarily turn its foot into a position simulating clubfoot. In addition, the foot should be visualized away from the uterine wall. Three-dimensional ultrasound, if available, can provide a clear image, but is not essential for diagnosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78391 \" href=\"mobipreview.htm?40/44/41679\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    When clubfoot is suspected, the sonographer should perform a complete anatomic survey, fetal echocardiogram, and evaluate the intrauterine environment specifically looking for fetal compression or crowding by fibroids, amniotic bands, or synechiae. The presence of both polyhydramnios and clubfoot suggests a central neurologic abnormality that has affected lower limb movement and swallowing.",
"   </p>",
"   <p>",
"    Prenatal detection of clubfoot is higher when the condition is bilateral or associated with other anomalies. As an example, in a series of children with isolated clubfoot, accurate prenatal diagnosis was twice as likely when the condition was bilateral",
"    <span class=\"nowrap\">",
"     (34/74)",
"    </span>",
"    compared to unilateral",
"    <span class=\"nowrap\">",
"     (17/73)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/2\">",
"     2",
"    </a>",
"    ]. In another study, no fetus with clubfoot was missed when there were associated congenital abnormalities (see below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal detection of clubfoot has improved in the past decade, from 25 to almost 80 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/2,9,10\">",
"     2,9,10",
"    </a>",
"    ]. This is related to better equipment, expertise, and increased sonographic screening throughout pregnancy. Imperfect midtrimester prenatal diagnosis does not necessarily represent poor sensitivity of ultrasound; instead, it can be due to disease progression during the second half of pregnancy in conditions that affect fetal neuromuscular development or the progressive effect of long-term immobility on the flexibility of the joint. False positive rates as high as 40 percent have been reported for diagnosis of isolated clubfoot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/2,9\">",
"     2,9",
"    </a>",
"    ]. This is typically due to the ability and inclination of a normal fetus to adduct its foot.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Associated abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Associated abnormalities are observed in at least 10 percent of live born cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/11\">",
"     11",
"    </a>",
"    ], which is expected in view of the fact that clubfoot often occurs as part of a syndrome. Over 50 syndromes include clubfoot as a frequent or occasional finding. The prevalence of associated abnormalities is higher in prenatally ascertained cases. As an example, review of a large database of over 14,000 patients who underwent prenatal ultrasonography found 67 percent of fetuses with clubfoot had associated anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/8\">",
"     8",
"    </a>",
"    ]. Others have reported associated anomaly rates of 33 to 80 percent; the wide range may be related to the population studied (community versus tertiary care hospital) or advances in ultrasound equipment over time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/10,12-15\">",
"     10,12-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Associated anomalies are more common with bilateral than unilateral clubfoot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OBSTETRICAL MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Findings on ultrasound examination and their significance should be discussed with the patient, including information on treatment options (eg, surgical procedures, serial casting, observation) and prognosis. Referral to a genetic counselor and pediatrician or orthopedist who can discuss postnatal management issues can be useful. However, the severity of clubfoot and the need for postnatal surgery are difficult to predict prenatally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Fetal karyotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determination of fetal karyotype is recommended if there are additional anatomic abnormalities or other indications for invasive prenatal diagnoses (eg, suspected open neural tube defect) since these pregnancies are considered at higher risk of fetal karyotype abnormality. In one large series, aneuploidy was detected prenatally in 15 of 49 fetuses with clubfoot associated with other structural anomalies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/0/23562?source=see_link&amp;anchor=H7#H7\">",
"     \"Congenital cytogenetic abnormalities\", section on 'Fetuses with congenital anomalies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no consensus as to whether amniocentesis should be offered when the only indication for karyotyping is the presence of an isolated clubfoot (unilateral or bilateral). The argument against routine karyotyping of fetuses with isolated clubfoot is that the risks associated with amniocentesis may be greater than the risk of an abnormal karyotype. A literature review including 13 studies found 8 cases of aneuploidy among 463 cases of isolated clubfoot (1.7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/15\">",
"     15",
"    </a>",
"    ]. The karyotype abnormalities were 47 XXY (two cases), trisomy 21 (two cases), 47 XYY (two cases), trisomy 18 (one case), 47 XXX (1 case). The fact that the largest of the studies consisted of only 68 fetuses with isolated clubfoot limits our ability to make a confident assessment of the risk of karyotypic abnormalities in these cases and suggests the underlying risk of chromosome anomalies among isolated clubfoot remains to be determined.",
"   </p>",
"   <p>",
"    In our practice, we offer prenatal karyotyping for isolated clubfoot because there have been numerous reports of karyotypically abnormal infants who were not suspected prenatally because ultrasound failed to detect associated abnormalities that were present. In one such report, 19 percent of fetuses with isolated clubfoot at 18 to 23 weeks of gestation were found to have associated anomalies on a subsequent ultrasound examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/13\">",
"     13",
"    </a>",
"    ]. Furthermore, the reliability of the low estimate of risk of chromosomal abnormality is limited by the small number of cases in the reports.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antenatal and intrapartum care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prenatal diagnosis of isolated clubfoot does not alter antenatal or intrapartum maternal care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no prenatal treatments. Postnatal treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/29/7639?source=see_link\">",
"     \"Lower extremity positional deformations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RECURRENCE RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough examination of the newborn or stillborn is necessary, as the presence of a syndrome will influence counseling on the mode of inheritance.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For parents without clubfoot, the overall risk of recurrent isolated clubfoot depends upon the sex of the first affected child: it is 2 percent after an affected male and 5 percent after an affected female.",
"     </li>",
"     <li>",
"      If both a parent and a child are affected, then the recurrence risk is as high as 25 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/18\">",
"       18",
"      </a>",
"      ]. Pedigree analyses have suggested a single gene may be involved; recessive patterns (autosomal and x-linked) and, less commonly, variably penetrant autosomal dominant patterns have been described [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33141/abstract/19-22\">",
"       19-22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Couples with an affected pregnancy should receive genetic counseling and be offered a targeted ultrasound in future pregnancies. There are no preventative therapies available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clubfoot (talipes equinovarus) refers to a developmental deformity of the foot in which one or both feet are excessively plantar flexed, with the forefoot swung medially and the sole facing inward. It occurs bilaterally in 30 to 50 percent of cases. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Prevalence and epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clubfoot can be secondary to factors intrinsic or extrinsic to the fetus; most cases are idiopathic. The prognosis depends upon several factors, including the severity of the defect and the presence of additional structural",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chromosomal abnormalities. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The sonographic diagnosis is based upon visualization of the plantar surface of the fetal foot in the same sagittal plane as both lower extremity bones (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52044 \" href=\"mobipreview.htm?36/43/37553\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79257 graphicRef59703 graphicRef72507 \" href=\"mobipreview.htm?35/18/36136\">",
"       image 2A-C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest an amniocentesis for karyotype if there are associated abnormalities or indications for invasive prenatal diagnoses (eg, abnormal maternal analytes), given the increased risk of aneuploidy. We perform amniocentesis in the setting of isolated clubfoot because associated abnormalities may not be detected by ultrasound and small numbers of karyotypic results from these cases limit the reliability of published estimates of risk. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fetal karyotype'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The antenatal diagnosis of isolated clubfoot does not alter antepartum or intrapartum maternal care. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Antenatal and intrapartum care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no prenatal treatment. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For parents without clubfoot, the overall risk of recurrent isolated clubfoot depends upon the sex of the first affected child: it is 2 percent after an affected male and 5 percent after an affected female. If both a parent and a child are affected, then the recurrence risk is as high as 25 percent. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Recurrence risk'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/1\">",
"      Wynne-Davis, R. Genetic and environmental factors in the etiology of talipes equinovarus. Clin Orthop 1972; 84:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/2\">",
"      Keret D, Ezra E, Lokiec F, et al. Efficacy of prenatal ultrasonography in confirmed club foot. J Bone Joint Surg Br 2002; 84:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/3\">",
"      Victoria-Diaz A, Victoria-Diaz J. Pathogenesis of idiopathic clubfoot. Clin Orthop Relat Res 1984; :14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/4\">",
"      Kawashima T, Uhthoff HK. Development of the foot in prenatal life in relation to idiopathic club foot. J Pediatr Orthop 1990; 10:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/5\">",
"      Dietz F. The genetics of idiopathic clubfoot. Clin Orthop Relat Res 2002; :39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/6\">",
"      Benacerraf BR, Frigoletto FD. Prenatal ultrasound diagnosis of clubfoot. Radiology 1985; 155:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/7\">",
"      Bronshtein M, Zimmer EZ. Transvaginal ultrasound diagnosis of fetal clubfeet at 13 weeks, menstrual age. J Clin Ultrasound 1989; 17:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/8\">",
"      Treadwell MC, Stanitski CL, King M. Prenatal sonographic diagnosis of clubfoot: implications for patient counseling. J Pediatr Orthop 1999; 19:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/9\">",
"      Mammen L, Benson CB. Outcome of fetuses with clubfeet diagnosed by prenatal sonography. J Ultrasound Med 2004; 23:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/10\">",
"      Offerdal K, Jebens N, Blaas HG, Eik-Nes SH. Prenatal ultrasound detection of talipes equinovarus in a non-selected population of 49 314 deliveries in Norway. Ultrasound Obstet Gynecol 2007; 30:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/11\">",
"      Yamahota, H. A clinical, genetic and epidemiologic study of congenital club foot. Jpn J Hum Genet 1979; 24:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/12\">",
"      Canto MJ, Cano S, Palau J, Ojeda F. Prenatal diagnosis of clubfoot in low-risk population: associated anomalies and long-term outcome. Prenat Diagn 2008; 28:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/13\">",
"      Bakalis S, Sairam S, Homfray T, et al. Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population. Ultrasound Obstet Gynecol 2002; 20:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/14\">",
"      Sharma R, Stone S, Alzouebi A, et al. Perinatal outcome of prenatally diagnosed congenital talipes equinovarus. Prenat Diagn 2011; 31:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/15\">",
"      Lauson S, Alvarez C, Patel MS, Langlois S. Outcome of prenatally diagnosed isolated clubfoot. Ultrasound Obstet Gynecol 2010; 35:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/16\">",
"      Tillett RL, Fisk NM, Murphy K, Hunt DM. Clinical outcome of congenital talipes equinovarus diagnosed antenatally by ultrasound. J Bone Joint Surg Br 2000; 82:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/17\">",
"      Swamy R, Reichert B, Lincoln K, Lal M. Foetal and congenital talipes: interventions and outcome. Acta Paediatr 2009; 98:804.",
"     </a>",
"    </li>",
"    <li>",
"     Wynne-Davis R. Family studies and the cause of congenital club foot. J Bone Joint Surg Am 1964a; 46:464.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/19\">",
"      Wang JH, Palmer RM, Chung CS. The role of major gene in clubfoot. Am J Hum Genet 1988; 42:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/20\">",
"      de Andrade M, Barnholtz JS, Amos CI, et al. Segregation analysis of idiopathic talipes equinovarus in a Texan population. Am J Med Genet 1998; 79:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/21\">",
"      Rebbeck TR, Dietz FR, Murray JC, Buetow KH. A single-gene explanation for the probability of having idiopathic talipes equinovarus. Am J Hum Genet 1993; 53:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33141/abstract/22\">",
"      Cowell HR, Wein BK. Genetic aspects of club foot. J Bone Joint Surg Am 1980; 62:1381.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6782 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-EFB8DDA1F5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33141=[""].join("\n");
var outline_f32_23_33141=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE AND EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EMBRYOLOGY OF FOOT DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ANATOMY OF CLUBFOOT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Associated abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OBSTETRICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Fetal karyotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antenatal and intrapartum care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RECURRENCE RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6782\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6782|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?36/43/37553\" title=\"diagnostic image 1\">",
"      Sonogram normal fetal foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?29/23/30064\" title=\"diagnostic image 2A\">",
"      Clubfoot1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/59/29616\" title=\"diagnostic image 2B\">",
"      Clubfoot2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?30/24/31105\" title=\"diagnostic image 2C\">",
"      Clubfoot3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?40/44/41679\" title=\"diagnostic image 3\">",
"      3-D ultrasound of club foot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6782|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/44/6850\" title=\"picture 1\">",
"      Clubfoot infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6782|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/20/41292\" title=\"table 1\">",
"      Causes of clubfoot",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/0/23562?source=related_link\">",
"      Congenital cytogenetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/29/7639?source=related_link\">",
"      Lower extremity positional deformations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_23_33142="Mortality HTN over 65 years";
var content_f32_23_33142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F57839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F57839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Joint effect of systolic and diastolic blood pressure on mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 396px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among participants in the NHANES II who were &ge;65 years of age, the figure shows a three dimensional surface representing the relative risk for all-cause mortality (vertical axis) with different combinations of the diastolic blood pressure (right diagonal arrow axis) and the systolic blood pressure (left diagonal arrow axis). For a fixed diastolic blood pressure, for example, the effect of different systolic blood pressures can be evaluated by following the risk surface along lines parallel to the systolic blood pressure axis. This effect is known as the conditional effect of systolic blood pressure. Similarly, for a fixed systolic blood pressure, the conditional effect of diastolic blood pressure can be evaluated by following the risk surface along lines parallel to the diastolic blood pressure axis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Pastor-Barriuso R, et al. Ann Intern Med 2003; 139:731.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33142=[""].join("\n");
var outline_f32_23_33142=null;
var title_f32_23_33143="Lymphoma bone histology";
var content_f32_23_33143=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F54630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F54630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Primary lymphoma of bone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Specimen of bone from the right superior ilium of a 21-year-old female. An infiltrate of large lymphoid cells with prominent nucleoli is seen on histologic evaluation of this primary bone lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Heather Pacholke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33143=[""].join("\n");
var outline_f32_23_33143=null;
var title_f32_23_33144="Tumor spread into leptomeningeal space";
var content_f32_23_33144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F78434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F78434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Pathophysiology of tumor spread into the leptomeningeal space",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The figure at the left illustrates a metastasis to the skull (A), with cells infiltrating through the dura into the subarachnoid space (B), and subsequently down the virchow-Robin spaces into the brain (C). Cells may also be found circulating in the blood as seen in the sagittal sinus (D). The figure at the right illustrates tumor cells entering the subarachnoid space from the vertebral body through connecting blood vessels (E) or from the paravertebral space along nerve sheaths (F).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Alexis Demopoulos, MD, and Jerome Posner, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33144=[""].join("\n");
var outline_f32_23_33144=null;
var title_f32_23_33145="Silicosis";
var content_f32_23_33145=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Silicosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33145/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33145/contributors\">",
"     Cecile Rose, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33145/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33145/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33145/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33145/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/23/33145/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silicosis refers to a spectrum of pulmonary diseases caused by inhalation of free crystalline silica (silicon dioxide). The written record of occupational lung disease caused by silica inhalation extends back to ancient Egypt and Greece. Despite a clear understanding of how to prevent this disease, new cases of silicosis continue to occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/1-6\">",
"     1-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) statement on the adverse effects of crystalline silica exposure, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Workers in a broad range of industries are exposed to crystalline silica (",
"    <a class=\"graphic graphic_table graphicRef55812 \" href=\"mobipreview.htm?15/58/16299\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/5,7,8\">",
"     5,7,8",
"    </a>",
"    ]. Up to 200,000 miners and 1.7 million non-mining workers in the United States have experienced significant occupational exposure to inhaled silica, and new cases of silicosis are recognized worldwide every year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is estimated that there were between 3600 and 7300 cases per year of silicosis in the United States between 1987 and 1996 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/11\">",
"     11",
"    </a>",
"    ]. During that decade, nearly 3000 deaths were attributed to silicosis in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/12\">",
"     12",
"    </a>",
"    ]. Still, the overall mortality attributable to silicosis has decreased substantially in the United States over the past 30 years, largely because of improved workplace protection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     FORMS OF SILICA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silica (silicon dioxide) is the most abundant mineral on earth. Silica exists in both crystalline and amorphous forms. Amorphous forms, including vitreous silica and diatomite (formed from skeletons of prehistoric marine organisms), are relatively nontoxic after inhalation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/15\">",
"     15",
"    </a>",
"    ]. In contrast, inhaled crystalline silica is associated with a spectrum of pulmonary diseases.",
"   </p>",
"   <p>",
"    The toxicity of crystalline silica appears to result from the ability of crystalline silica surfaces to interact with aqueous media, to generate oxygen radicals, and to injure target pulmonary cells such as alveolar macrophages. Resultant generation of inflammatory cytokines (eg, interleukin-1 and tumor necrosis factor beta) by target cells lead to cytokine networking between inflammatory cells and resident pulmonary cells, resulting in inflammation and fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Crystalline forms of silica include quartz, cristobalite, and tridymite. Quartz is the most common type, and is a major component of rocks including granite, slate, and sandstone. Granite contains about 30 percent free silica, slate about 40 percent, and sandstone is almost pure silica [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/17\">",
"     17",
"    </a>",
"    ]. Cristobalite and tridymite occur naturally in lava and are formed when quartz or amorphous silica is subjected to very high temperatures. Generation of cristobalite, a particularly toxic form of respirable silica, also occurs during high-temperature industrial processes involving amorphous silica or quartz.",
"   </p>",
"   <p>",
"    \"Free\" crystalline silica is unbound to other minerals. \"Combined\" forms, or silicates, are compounds in which silica is bound to other minerals. Examples of silicates used in industry include asbestos, talc (Mg3Si4O10(OH)2), and kaolinite (Al2Si2O5(OH)4), a major component of kaolin (china clay) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/18\">",
"     18",
"    </a>",
"    ]. The pulmonary effects of asbestos inhalation are substantial, and are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=see_link\">",
"     \"Asbestosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SILICA IN THE WORK ENVIRONMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any occupation that disturbs the earth's crust or involves processing or using silica-containing rock or ores has potential risk for silicosis. Thus, silicosis can occur in many industries and work settings including mining, quarrying, sandblasting, masonry, foundry work, and ceramics (",
"    <a class=\"graphic graphic_table graphicRef55812 \" href=\"mobipreview.htm?15/58/16299\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Silicosis has been recognized in miners since ancient times. Underground mining for metals often involves removal of quartz-rich ores from the earth. Silicosis can result from mining, quarrying, or construction processes that involve drilling, cutting, grinding, blasting, or crushing the earth's crust. Underground coal mining can cause silicosis, particularly when tunneling through rock with high silica content or when using sand as a friction material on rails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/19\">",
"     19",
"    </a>",
"    ]. Although dust exposure levels are generally lower in surface and strip mines, silicosis also occurs in this setting, particularly among drillers and their assistants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occupations that involve crushing or grinding of quartz-containing materials are also hazardous. Sandblasting generates respirable aerosols of silica, and is associated with an especially increased risk for silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. The very high risk associated with sandblasting may be due to generation of freshly fractured silica particles, which appear to be particularly toxic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/26\">",
"     26",
"    </a>",
"    ]. The United Kingdom restricted use of abrasives containing silica in 1949, and other European countries abandoned sandblasting during the 1960s. In contrast, there are no special restrictions on the use of sand for abrasive blasting in the United States, except in the underground mine environment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Foundry workers may also have significant exposure to aerosolized silica [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/28\">",
"     28",
"    </a>",
"    ]. In foundries, metal castings are made by pouring molten metal into molds. These molds generally contain finely milled quartz sands, and exposure to respirable crystalline silica aerosols occurs both when the mold is knocked off the cast and when the cast is cleaned or polished. These aerosols often contain cristobalite, which is formed as a result of the intense heat associated with producing casts and is particularly toxic. Production of silica flour, sand, concrete, and silica-based ceramics are also associated with an increased risk of silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/5,29,30\">",
"     5,29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The short list of high-risk industries specifically noted above is not complete, as silicosis can occur in many dusty settings, even ones where risk was not previously appreciated (",
"    <a class=\"graphic graphic_table graphicRef55812 \" href=\"mobipreview.htm?15/58/16299\">",
"     table 1",
"    </a>",
"    ). As an example, nine cases of silicosis were confirmed among dental laboratory technicians in the United States between 1994 and 2000 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, high rates of silicosis have been described in Turkish workers using silica to sandblast denim [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/25,31\">",
"     25,31",
"    </a>",
"    ]. There has been increasing recognition that construction activities can be associated with silicosis and that work in agriculture can lead to significant exposures to respirable silica [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/5,32\">",
"     5,32",
"    </a>",
"    ]. Finally, although occupation is the major risk factor for silicosis, there have been rare case reports of chronic silicosis after environmental exposures in regions where soil silica content is high and dust storms are common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several clinical presentations of disease have been described. Chronic and accelerated silicosis share many common radiographic features, and are clinically differentiated on the interval between exposure and the development of symptoms. Acute silicosis is associated with unique pathologic and radiologic features, and occurs within weeks to a few years after overwhelming exposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic silicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic silicosis develops slowly, usually appearing 10 to 30 years after first exposure. It is not uncommon for silicosis to first become radiographically apparent many years after cessation of employment in a job associated with exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/34\">",
"     34",
"    </a>",
"    ]. Chronic silicosis usually has the radiographic pattern described below as simple silicosis. In a minority of those with chronic disease, nodules coalesce resulting in progressive massive fibrosis (PMF).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Accelerated silicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accelerated silicosis develops within 10 years of initial exposure. Accelerated silicosis is associated with high-level exposure to silica, and has the same radiographic appearance as chronic silicosis. Accelerated silicosis is differentiated from chronic disease only by its more rapid development following first exposure. Patients who develop silicosis after a short time period are at increased risk for the development of PMF, and may be at greater risk of complications.",
"   </p>",
"   <p>",
"    The clinical presentation of both chronic and accelerated silicosis is variable. Affected individuals may be asymptomatic and only present with an abnormal chest radiograph. Among symptomatic patients, chronic cough and dyspnea on exertion are common, and become more frequent and severe with worsening radiographic abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/35\">",
"     35",
"    </a>",
"    ]. Physical examination of the chest is usually unremarkable, although a variety of abnormal breath sounds, including fine crackles, coarse crackles (often at end inspiration), rhonchi,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    wheezes, have been reported to occur in a substantial proportion of affected individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Progressive massive fibrosis (PMF) is associated with more severe symptoms than simple silicosis. The progressive coalescence of silicotic nodules leads to respiratory impairment, including air trapping and emphysema. Physical examination frequently demonstrates decreased or other abnormal breath sounds. Signs of chronic respiratory failure and cor pulmonale may be present. Crackles do not occur as a result of the interstitial changes, but adventitious sounds may be present. PMF is not specifically associated with digital clubbing and, if present, another etiology should be sought. Digital clubbing does not commonly occur in patients with PMF, and this physical finding should prompt careful assessment for hypoxemia and other complications of silicosis including malignancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Acute silicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute silicosis develops after exposure to high concentrations of respirable crystalline silica and results in symptoms within a few weeks to a few years after the initial exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/3,37-42\">",
"     3,37-42",
"    </a>",
"    ]. Acute silicosis is characterized by rapid onset of symptoms including cough, weight loss, fatigue, and sometimes pleuritic pain. These symptoms may precede significant radiologic findings. On physical examination, crackles are usually present. The prognosis of patients with acute silicosis is very poor. Patients rapidly develop cyanosis, cor pulmonale, and respiratory failure. Survival after onset of symptoms is typically less than four years, with mycobacterial and fungal infections frequently complicating the clinical course.",
"   </p>",
"   <p>",
"    Acute silicosis is rare, and presents radiographically with a characteristic basilar alveolar filling pattern,",
"    <strong>",
"     without",
"    </strong>",
"    rounded opacities or lymph node calcifications. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Silicoproteinosis'",
"    </a>",
"    below.) In contrast, most individuals with extremely high silica exposures initially display radiographic features identical to those of simple silicosis, which progress to PMF over a period of as few as four to five years. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Accelerated silicosis'",
"    </a>",
"    above.) The reason that some individuals develop acute silicosis while others develop accelerated silicosis after overwhelming silica exposure is not known; genetic factors may play a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/4,43,44\">",
"     4,43,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Associated conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silicosis is associated with an increased risk of lung cancer, mycobacterial infection, autoimmune disorders, airflow obstruction, and chronic bronchitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lung cancer &ndash; The International Agency for Research on Cancer (IARC) determined in 1997 that there was sufficient evidence for carcinogenicity of crystalline silica [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/45\">",
"       45",
"      </a>",
"      ]. Since then, additional evidence for a relationship has accumulated, although the relationship may not increase linearly to the highest levels of silica exposure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/46,47\">",
"       46,47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mycobacterial infection &ndash; Strong evidence for associations between silicosis and both tuberculous and nontuberculous mycobacterial infection has been provided by several studies of South African gold miners [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/48-51\">",
"       48-51",
"      </a>",
"      ]. Patients with silicosis are at very high risk of active pulmonary tuberculosis and should be screened for evidence of latent infection. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Tuberculosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Connective tissue disease &ndash; Among the connective tissue disorders, the older literature has most strongly associated silicosis with scleroderma. However, a significant association with rheumatoid arthritis has also been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/52\">",
"       52",
"      </a>",
"      ]. Associations with systemic lupus erythematosus, mixed connective tissue disease, systemic vasculitis, and end-stage renal disease are less well established [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/6,52-58\">",
"       6,52-58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Airflow limitation and chronic bronchitis &ndash; Silica exposure, even in the absence of findings on conventional chest radiograph, is associated with excessive decline in spirometric performance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/59-61\">",
"       59-61",
"      </a>",
"      ]. Cough and sputum production are common among workers with occupational exposure to silicosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, three key elements play a role in the diagnosis of silicosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of silica exposure sufficient to cause the degree of illness and the appropriate latency from the time of first exposure",
"     </li>",
"     <li>",
"      Chest imaging (usually a conventional chest radiograph) that shows opacities consistent with silicosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/62\">",
"       62",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Absence of another diagnosis more likely to be responsible for the observed abnormalities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Determining whether the worker's occupational silica exposure is sufficient to cause silicosis can be difficult. This requires information about the work environment and the worker's exposures. Silicosis occurs in association with industrial processes where silica particles of respirable size are generated and aerosolized. Workers exposed to sandblasting, drilling into siliceous rock, or finely milled silica flour are at particularly increased risk (",
"    <a class=\"graphic graphic_table graphicRef55812 \" href=\"mobipreview.htm?15/58/16299\">",
"     table 1",
"    </a>",
"    ). Current workplace exposure limits in the US are not fully protective of all exposed workers. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Silica in the work environment'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chest imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silica exposure can cause several distinct clinical and radiographic patterns of pulmonary disease. The three main radiographic presentations of silicosis are simple silicosis, progressive massive fibrosis (PMF), and silicoproteinosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Simple silicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simple silicosis refers to a profusion of small (less than 10 mm in diameter) nodular opacities (nodules). The nodules are generally rounded but can be irregular, and are distributed predominantly in the upper lung zones (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70007 graphicRef79172 \" href=\"mobipreview.htm?7/28/7624\">",
"     image 1A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/34/14888?source=see_link\">",
"     \"Differential diagnosis and evaluation of multiple pulmonary nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Progressive massive fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progressive massive fibrosis (PMF, or conglomerate silicosis) occurs when these small opacities gradually enlarge and coalesce to form larger, upper- or mid-zone opacities more than 10 mm in diameter (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77392 \" href=\"mobipreview.htm?8/9/8336\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/19\">",
"     19",
"    </a>",
"    ]. As these opacities progressively enlarge, the hila are retracted upward in association with upper lobe fibrosis and lower lobe hyperinflation.",
"   </p>",
"   <p>",
"    Hilar adenopathy with prominent calcification is often present. The opacities of PMF can be asymmetrical, and may mimic a neoplastic process. Cavitation may also be present in advanced disease, or in the setting of mycobacterial superinfection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/62/5096?source=see_link\">",
"     \"Evaluation of diffuse lung disease by conventional chest radiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Silicoproteinosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silicoproteinosis occurs following overwhelming exposure to respirable crystalline silica over a short time, and is the radiographic hallmark of acute silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/37,38,63-65\">",
"     37,38,63-65",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Acute silicosis'",
"    </a>",
"    above.) The chest radiograph demonstrates a characteristic basilar alveolar filling pattern,",
"    <strong>",
"     without",
"    </strong>",
"    rounded opacities or lymph node calcifications (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54371 \" href=\"mobipreview.htm?11/32/11791\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Over time, these features progress from a pattern of lower zone alveolar filling to large masses of coalesced parenchymal tissue in the mid- and lower zones, which are typically bilateral but not always symmetrical. This unusual condition shares many radiographic and histopathologic features with pulmonary alveolar proteinosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/37,39,63\">",
"     37,39,63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/62/8168?source=see_link\">",
"     \"Clinical manifestations and etiology of pulmonary alveolar proteinosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diseases capable of mimicking the radiographic appearance of silicosis include infections (eg, miliary distribution of mycobacterial or fungal disease), pulmonary malignancy (a consideration when the coalesced lesions of progressive massive fibrosis are unilateral or asymmetric), rheumatoid nodules (referred to as Caplan's Syndrome in the presence of pneumoconiosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/66\">",
"     66",
"    </a>",
"    ]), sarcoidosis, coal worker's pneumoconiosis, or rarely, pulmonary alveolar proteinosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/34/14888?source=see_link\">",
"     \"Differential diagnosis and evaluation of multiple pulmonary nodules\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several reports have compared chest radiograph appearance to pathologic examination of the lungs at autopsy in detecting silicosis. In a study of more than 500 South African gold miners that compared autopsy results and radiographs scored using the International Labor Office (ILO) classification system profusion classes of",
"    <span class=\"nowrap\">",
"     1/0,",
"    </span>",
"    <span class=\"nowrap\">",
"     1/1,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     1/2",
"    </span>",
"    as cutoffs, sensitivities were found to be 50, 37, and 25 percent, respectively, and specificities 89, 96, and 100 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/67\">",
"     67",
"    </a>",
"    ]. A subsequent smaller study of 241 South African gold miners evaluated use of \"miniradiographs\" with cutoffs at ILO profusion categories",
"    <span class=\"nowrap\">",
"     0/1,",
"    </span>",
"    <span class=\"nowrap\">",
"     1/0,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     1/1.",
"    </span>",
"    Sensitivities were 89, 74, and 71 percent, respectively, and specificities were 73, 87, and 96 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/68\">",
"     68",
"    </a>",
"    ]. Reasons for improved sensitivity in the second study were unclear. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/62/5096?source=see_link\">",
"     \"Evaluation of diffuse lung disease by conventional chest radiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Performance of conventional chest CT scan and high-resolution CT scan of the chest (HRCT) for the diagnosis of silicosis is usually unnecessary when the radiographic image shows early stage interstitial opacities. As with other interstitial lung diseases, HRCT has been shown to improve sensitivity and significantly reduce inter-reader variability compared to conventional radiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is general agreement that",
"    <span class=\"nowrap\">",
"     CT/HRCT",
"    </span>",
"    is superior to conventional chest radiography for documentation of PMF lesions and emphysematous changes associated with silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/70-76\">",
"     70-76",
"    </a>",
"    ]. Although pleural effusions are unusual, pleural thickening appears to be common, especially among patients with more severe disease. In a series of 110 patients with biopsy proven silicosis followed for a mean of 14 years, pleural effusions were noted in 12 patients (11 percent), but pleural thickening was present in 64 patients (58 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Workers exposed to respirable crystalline silica may develop a range of pulmonary function test abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/59-61\">",
"     59-61",
"    </a>",
"    ]. In a study of 1028 foundry workers without chest radiograph abnormalities, there was a 1.1 mL per year decline in FEV1 for each mg per cubic meter or mean silica exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/59\">",
"     59",
"    </a>",
"    ]. The presence of even mild radiographic findings of chronic or accelerated silicosis is associated, on average, with a greater degree of abnormality in pulmonary function. Spirometry shows a mixed picture of obstructive and restrictive ventilatory impairment with decreased FEV1 and",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulmonary function, on average, worsens in association with worsening radiographic abnormalities of chronic or accelerated silicosis. PMF is associated with the worst pulmonary function abnormalities, including decreased compliance, decreased FEV1 and",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    ratio, and decreased diffusing capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/35,71\">",
"     35,71",
"    </a>",
"    ]. In a number of studies using chest CT scan to evaluate lung parenchyma in chronic or accelerated silicosis, lung function abnormalities correlated better with the emphysematous changes of silicosis than the nodular changes of silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/72,73,76\">",
"     72,73,76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the three clinical requirements for the diagnosis of silicosis are met, additional evaluation is not necessary to make the diagnosis. In rare instances the diagnosis cannot be made clinically, and biopsy of the lung is necessary to exclude other diagnoses. The traditional view has been that an open lung biopsy is preferred due to the chance of pneumothorax after transbronchial lung biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/78\">",
"     78",
"    </a>",
"    ]. The increased risk for pneumothoraces in silicosis may be explained by the presence of stiff upper zones while emphysematous changes are present in the lower zones. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/26/424?source=see_link\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these concerns, successful use of transbronchial lung biopsy in conjunction with bronchoalveolar lavage has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/79\">",
"     79",
"    </a>",
"    ]. In one case, bronchoalveolar lavage documented a neutrophilic alveolitis, and energy dispersive x-ray analysis confirmed the presence of silica within alveolar macrophages, despite the absence of birefringent crystal particles. Transbronchial biopsy showed fibrocellular nodules in the parenchyma. Taken together, these findings were deemed consistent with the diagnosis of silicosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/36/16968?source=see_link\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The earliest histopathologic changes identifiable in workers with chronic low-level exposure to free crystalline silica are dust-laden macrophages and loose reticulin fibers in the peribronchial, perivascular, and paraseptal or subpleural areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/16,80\">",
"     16,80",
"    </a>",
"    ]. Silicosis in hilar lymph nodes may precede parenchymal silicosis, and lymph node fibrosis may impair silica clearance and contribute to development of parenchymal fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/81\">",
"     81",
"    </a>",
"    ]. Silicotic nodules, the pathologic hallmark of silicosis, develop over time and in association with increased exposure. The central zone of a silicotic nodule is hyalinized and composed of concentrically arranged collagen fibers. The peripheral zone is whorled and becomes less organized toward the edges. This outer zone contains macrophages, lymphocytes, and lesser amounts of loosely formed collagen and is the site of active enlargement of the nodule and of ongoing inflammation.",
"   </p>",
"   <p>",
"    As the disease progresses, the periphery of the silicotic nodule moves farther from the hyalinized center, enmeshing small airways, pleura, and blood and lymphatic vessels in the fibrotic process (",
"    <a class=\"graphic graphic_picture graphicRef58232 \" href=\"mobipreview.htm?29/47/30456\">",
"     picture 1",
"    </a>",
"    ). Coalescence of silicotic nodules forms the PMF lesion. As these aggregates enlarge, the center of the PMF lesions may undergo ischemic necrosis and cavitate. Superimposed mycobacterial infection can also lead to cavitation.",
"   </p>",
"   <p>",
"    The histopathology of acute silicosis is different from that of chronic or accelerated silicosis. Silicotic nodules are rarely seen, and, if present, are usually poorly developed. The most impressive finding is alveolar filling with proteinaceous material, consisting largely of phospholipids or surfactant (or surfactant-like material) that stain with periodic acid-Schiff (PAS) reagent. The interstitium is thickened with inflammatory cells; a minimal amount of pulmonary fibrosis is typically present. On electron microscopic examination, the alveoli are lined with prominent epithelial cells, the majority of which are hypertrophic type II pneumocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/82\">",
"     82",
"    </a>",
"    ]. In addition, desquamated pneumocytes, macrophages, and silica particles are found in the alveolar spaces. The histologic appearance of acute silicosis resembles that of idiopathic alveolar proteinosis (",
"    <a class=\"graphic graphic_picture graphicRef76748 \" href=\"mobipreview.htm?26/3/26678\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/62/8168?source=see_link\">",
"     \"Clinical manifestations and etiology of pulmonary alveolar proteinosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven specific therapy for any form of silicosis. Symptomatic therapy should include treatment of airflow limitation with bronchodilators, aggressive management of respiratory tract infection with antibiotics, and use of supplemental oxygen (if indicated) to prevent complications of chronic hypoxemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42215?source=see_link\">",
"     \"Long-term supplemental oxygen therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient should avoid any on-going exposure to respirable silica. Patients should be referred for appropriate counseling concerning benefits, such as worker's compensation, to which they may be entitled.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tuberculosis (TB) is a long recognized and well-established complication of silicosis and should always be suspected when a patient with silicosis develops constitutional symptoms, worsening respiratory impairment, or changes in the chest radiograph. Cavitation of a PMF lesion is a particularly concerning finding. It has been recommended that patients with established silicosis, or those with prolonged exposure to inhaled crystalline silica, undergo tuberculin skin testing using purified protein derivative (PPD). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A PPD reaction &gt;10 mm is considered positive in this population. Latent TB infection should be treated in accordance with established guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/83\">",
"     83",
"    </a>",
"    ]. It is important to evaluate for active TB using microbiologic techniques if a positive",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    is documented, since silicosis can mask the radiographic changes of active TB. In addition, the risk of active TB in patients with silicosis and a positive PPD is markedly increased. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Active TB should be treated with multiple antituberculous drugs. Some reports indicate that short course multidrug treatment of latent TB infection may not be effective in the presence of silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/84\">",
"     84",
"    </a>",
"    ]. Older studies suggested that antituberculous chemotherapy should be given for an extended period, ranging from more than a year to a lifetime [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/85\">",
"     85",
"    </a>",
"    ]. However, subsequent studies have shown successful outcomes and acceptable relapse rates with shorter treatment regimens of five and nine months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. The largest study found a lower relapse rate when the usual multidrug regimen was given for eight months instead of six [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/88\">",
"     88",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS), Centers for Disease Control (CDC), and Infectious Disease Society of American (IDSA) statement Treatment of Tuberculosis, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid therapy has been used in an attempt to interrupt the inflammation that leads to progressive silicosis, but no large, randomized clinical trials have demonstrated an impact of glucocorticoid therapy on the long-term clinical outcome of silicosis.",
"   </p>",
"   <p>",
"    In the largest study to date, a six-month trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    was carried out in 34 patients with chronic silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/89\">",
"     89",
"    </a>",
"    ]. Treatment resulted in statistically (although not clinically) significant improvements in lung volumes, carbon monoxide diffusing capacity, and partial pressure of arterial oxygen; a significant decrease in total cells recovered by bronchoalveolar lavage was also noted. Systemic glucocorticoid therapy has also been reported to be beneficial in accelerated and acute silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. In a case series, 27 of 43 patients with accelerated silicosis had initial improvement in spirometry and oxygen saturation after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    100 mg given intravenously for three days, however the beneficial effects appeared to wane over time despite monthly dexamethasone infusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Lung transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung transplantation should be considered for people with end-stage silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. One of the earliest reports of unilateral lung transplantation was in a 23-year-old man with acute silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/92\">",
"     92",
"    </a>",
"    ]. However, in a small series, lung transplant recipients with silicosis had a poorer long-term survival than those with idiopathic pulmonary fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/94\">",
"     94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26953?source=see_link\">",
"     \"Lung transplantation: General guidelines for recipient selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Experimental therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several experimental treatment measures have been proposed for use in patients with silicosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whole lung lavage has been attempted as a therapeutic measure, based on its ability to reduce pulmonary dust burden and remove inflammatory cells from the lung [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/95-98\">",
"       95-98",
"      </a>",
"      ]. While current data shows the procedure to be safe and technically feasible, its clinical utility is unclear. There is speculation that the continued recirculation of sequestered silica limits the potential benefit of this approach.",
"     </li>",
"     <li>",
"      Other experimental treatments of unknown utility include parenteral administration of a polymer, polyvinyl pyridine N-oxide (PVNO); inhalation of aluminum, and administration of tetrandrine, an active component of the Chinese traditional medicine \"han fang ji\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/16,99-105\">",
"       16,99-105",
"      </a>",
"      ]. Concerns about potential adverse consequences of such treatments have been expressed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silicosis is a preventable disease. As a consequence of better industrial hygiene practices, silicosis afflicts far fewer people in the United States than in the past. As a result of litigation not specifically related to the silica standard, the Occupational Safety and Health Administration (OSHA) has returned to a permissible exposure limit (PEL) for respirable silica at 10",
"    <span class=\"nowrap\">",
"     mg/m3",
"    </span>",
"    divided by (percent SiO",
"    <sub>",
"     2",
"    </sub>",
"    + 2) or 250 million particles per cubic foot divided by (percent SiO",
"    <sub>",
"     2",
"    </sub>",
"    + 5), after having enforced an exposure limit of 0.1",
"    <span class=\"nowrap\">",
"     mg/m3",
"    </span>",
"    respirable silica [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of studies suggest, however, that this permissible exposure limit is not protective of workers with exposure over an entire working lifetime [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/19,34,107,108\">",
"     19,34,107,108",
"    </a>",
"    ]. On the basis of such findings, the National Institute for Occupational Safety and Health (NIOSH) has recommended an exposure limit (REL) of 0.05",
"    <span class=\"nowrap\">",
"     mg/m3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/5,109\">",
"     5,109",
"    </a>",
"    ]. Unfortunately, noncompliance with even with the current PEL appears common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although primary prevention through exposure control is the critical component of silicosis prevention, health monitoring of workers with exposure to respirable crystalline quartz using chest radiographs and spirometry may assist in the early identification of people developing disease from their exposures. Efforts at secondary prevention only work if there are effective interventions resulting in reductions of quartz exposure for affected workers and others comparably exposed. Many industrialized countries mandate health surveillance for workers at risk of developing silicosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/111\">",
"     111",
"    </a>",
"    ]. A number of NIOSH publications are available addressing such issues as awareness of silica as a workplace hazard, environmental controls, personal protection, and medical monitoring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33145/abstract/22,112,113\">",
"     22,112,113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The crystalline forms of silica (eg, quartz, cristobalite, and tridymite) are associated with a spectrum of pulmonary diseases known collectively as silicosis. Quartz is a major component of granite, slate, and sandstone. Cristobalite is formed during high-temperature industrial processes involving amorphous silica and quartz. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Forms of silica'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Workers in a broad range of industries (eg, sandblasting, mining, masonry, foundry work, glass and ceramic manufacturing) are exposed to respirable silica (silicon dioxide). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Three radiographic patterns of silicosis have been described. Simple silicosis has multiple, upper lung zone nodules that are less than 10 mm in diameter and may be irregular. Progressive massive fibrosis occurs when the nodules of simple silicosis coalesce and are associated with hilar lymphadenopathy and calcification. Silicoproteinosis refers to a bibasilar alveolar filling pattern, similar to that of pulmonary alveolar proteinosis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Chest imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic silicosis appears 10 to 30 years after exposure and has the radiographic pattern of simple silicosis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chronic silicosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Accelerated silicosis develops within 10 years of the initial exposure and is associated with high level exposure. The radiographic pattern is that of simple silicosis although the development of radiographic abnormalities is more rapid. Patients with accelerated silicosis are at greater risk for progressive massive fibrosis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Accelerated silicosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms of acute silicosis develop within a few weeks to a few years of the initial exposure and include cough, weight loss, fatigue, and sometimes pleuritic pain. The radiographic pattern is that of silicoproteinosis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Acute silicosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of silicosis is usually based on a history of sufficient respirable silica exposure to cause the clinical findings, a compatible chest radiograph, and the absence of an alternative explanation. Lung biopsy is rarely needed. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conditions associated with silicosis include mycobacterial infection, airflow obstruction, chronic bronchitis, connective tissue disorders, and lung malignancy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Associated conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As there is no proven therapy for silicosis, efforts should be directed towards prevention through a comprehensive lung health protection program focused on exposure avoidance and use of personal protective equipment, when necessary. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Supportive care is recommended as no specific therapy has been established for any form of silicosis. Further exposure to respirable silica should be avoided, if possible. Symptomatic therapy should include treatment of airflow obstruction with bronchodilators, aggressive management of respiratory tract infection with antibiotics, and use of supplemental oxygen (if indicated) to prevent complications of chronic hypoxemia. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with advanced disease and no contraindications, we suggest referral for a lung transplant evaluation. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Lung transplantation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/1\">",
"      Brown HV. The history of industrial hygiene: a review with special reference to silicosis. Am Ind Hyg Assoc J 1965; 26:212.",
"     </a>",
"    </li>",
"    <li>",
"     Health effects of occupational exposure to respirable crystalline silica. NIOSH, Publication No. 2002-129. DHHHS (NIOSH), 2002.",
"    </li>",
"    <li>",
"     WHO. Concise international chemical assessment document 24. Crystalline silica, quartz. Wissenschaftliche Verlagsgesellschaft mbH; Stuttgart, 2000.",
"    </li>",
"    <li>",
"     Weissman DN, Banks DE. Silicosis. In: Interstitial Lung Disease, 4th ed, King TE Jr, Schwarz MI (Eds), B.C. Decker, Hamilton, ON, Canada 2003. p.387.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/5\">",
"      Valiante DJ, Schill DP, Rosenman KD, Socie E. Highway repair: a new silicosis threat. Am J Public Health 2004; 94:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/6\">",
"      Adverse effects of crystalline silica exposure. American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health. Am J Respir Crit Care Med 1997; 155:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/7\">",
"      Centers for Disease Control and Prevention (CDC). Silicosis in dental laboratory technicians--five states, 1994-2000. MMWR Morb Mortal Wkly Rep 2004; 53:195.",
"     </a>",
"    </li>",
"    <li>",
"     Work-Related Lung Diseases Surveillance Report. DHHS (NIOSH) publication 91-113. National Institute for Occupational Safety and Health, 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/9\">",
"      Banks DE, Balaan M, Wang ML. Silicosis in the 1990s, revisited. Chest 1997; 111:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/10\">",
"      Rosenman KD, Reilly MJ, Kalinowski DJ, Watt FC. Silicosis in the 1990s. Chest 1997; 111:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/11\">",
"      Rosenman KD, Reilly MJ, Henneberger PK. Estimating the total number of newly-recognized silicosis cases in the United States. Am J Ind Med 2003; 44:141.",
"     </a>",
"    </li>",
"    <li>",
"     NIOSH. Work-related lung disease surveillance report. Publication No. 2000-105. DHHS (NIOSH), Cincinnati, OH, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/13\">",
"      Centers for Disease Control and Prevention (CDC). Silicosis mortality, prevention, and control--United States, 1968-2002. MMWR Morb Mortal Wkly Rep 2005; 54:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/14\">",
"      Centers for Disease Control and Prevention (CDC). Silicosis-related years of potential life lost before age 65 years--United States, 1968-2005. MMWR Morb Mortal Wkly Rep 2008; 57:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/15\">",
"      Merget R, Bauer T, K&uuml;pper HU, et al. Health hazards due to the inhalation of amorphous silica. Arch Toxicol 2002; 75:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/16\">",
"      Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med 2005; 11:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/17\">",
"      Lapp NL. Lung disease secondary to inhalation of nonfibrous minerals. Clin Chest Med 1981; 2:219.",
"     </a>",
"    </li>",
"    <li>",
"     Gamble JF. Silicate pneumoconiosis. In: Occupational respiratory diseases, Merchant JA, (Ed), Publication No. DHHS (NIOSH) 86-102, Government Printing Office, Washington, DC 1986. p.243.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/19\">",
"      Wade WA, Petsonk EL, Young B, Mogri I. Severe occupational pneumoconiosis among West Virginian coal miners: one hundred thirty-eight cases of progressive massive fibrosis compensated between 2000 and 2009. Chest 2011; 139:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/20\">",
"      Banks DE, Bauer MA, Castellan RM, Lapp NL. Silicosis in surface coalmine drillers. Thorax 1983; 38:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/21\">",
"      Centers for Disease Control and Prevention (CDC). Silicosis screening in surface coal miners--Pennsylvania, 1996-1997. MMWR Morb Mortal Wkly Rep 2000; 49:612.",
"     </a>",
"    </li>",
"    <li>",
"     Request for Assistance in Preventing Silicosis and Deaths from Sandblasting. Publication No. 92-102. DHHS (NIOSH), 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/23\">",
"      Bailey WC, Brown M, Buechner HA, et al. Silico-mycobacterial disease in sandblasters. Am Rev Respir Dis 1974; 110:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/24\">",
"      Glindmeyer HW, Hammad YY. Contributing factors to sandblasters' silicosis: inadequate respiratory protection equipment and standards. J Occup Med 1988; 30:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/25\">",
"      Akgun M, Araz O, Akkurt I, et al. An epidemic of silicosis among former denim sandblasters. Eur Respir J 2008; 32:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/26\">",
"      Vallyathan V, Shi XL, Dalal NS, et al. Generation of free radicals from freshly fractured silica dust. Potential role in acute silica-induced lung injury. Am Rev Respir Dis 1988; 138:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/27\">",
"      Wagner GR. The inexcusable persistence of silicosis. Am J Public Health 1995; 85:1346.",
"     </a>",
"    </li>",
"    <li>",
"     Seaton A. Silicosis. In: Occupational Lung Diseases, Morgan WK, Seaton A (Eds), W.B. Saunders Company, Philadelphia 1995. p.222.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/29\">",
"      Johnson WM, Busnardo MS. Silicosis following employment in the manufacture of silica flour and industrial sand. J Occup Med 1993; 35:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/30\">",
"      Linch KD. Respirable concrete dust--silicosis hazard in the construction industry. Appl Occup Environ Hyg 2002; 17:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/31\">",
"      Bakan ND, &Ouml;zkan G, &Ccedil;amsari G, et al. Silicosis in denim sandblasters. Chest 2011; 140:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/32\">",
"      Archer JD, Cooper GS, Reist PC, et al. Exposure to respirable crystalline silica in eastern North Carolina farm workers. AIHA J (Fairfax, Va) 2002; 63:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/33\">",
"      Norboo T, Angchuk PT, Yahya M, et al. Silicosis in a Himalayan village population: role of environmental dust. Thorax 1991; 46:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/34\">",
"      Kreiss K, Zhen B. Risk of silicosis in a Colorado mining community. Am J Ind Med 1996; 30:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/35\">",
"      Wang XR, Christiani DC. Respiratory symptoms and functional status in workers exposed to silica, asbestos, and coal mine dusts. J Occup Environ Med 2000; 42:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/36\">",
"      Munakata M, Homma Y, Matsuzaki M, et al. Rales in silicosis. A correlative study with physiological and radiological abnormalities. Respiration 1985; 48:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/37\">",
"      Duchange L, Brichet A, Lamblin C, et al. [Acute silicosis. Clinical, radiologic, functional, and cytologic characteristics of the broncho-alveolar fluids. Observations of 6 cases]. Rev Mal Respir 1998; 15:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/38\">",
"      Chapman, E. Acute Silicosis. JAMA 1932; 98:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/39\">",
"      Buechner HA, Ansari A. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969; 55:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/40\">",
"      Suratt PM, Winn WC Jr, Brody AR, et al. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 1977; 115:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/41\">",
"      Gardner LU. Pathology of So-Called Acute Silicosis. Am J Public Health Nations Health 1933; 23:1240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/42\">",
"      Xipell JM, Ham KN, Price CG, Thomas DP. Acute silicoproteinosis. Thorax 1977; 32:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/43\">",
"      Yucesoy B, Vallyathan V, Landsittel DP, et al. Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med 2001; 39:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/44\">",
"      Honda K, Kimura A, Dong RP, et al. Immunogenetic analysis of silicosis in Japan. Am J Respir Cell Mol Biol 1993; 8:106.",
"     </a>",
"    </li>",
"    <li>",
"     International agency for research on cancer. IARC monographs on the evaluation of carcinogenic risks to humans: Silica, some silicates, coal dust, and para-aramid fibrils. World Health Organization; International Agency for Research on Cancer, 337, Geneva, Switzerland, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/46\">",
"      McDonald JC, McDonald AD, Hughes JM, et al. Mortality from lung and kidney disease in a cohort of North American industrial sand workers: an update. Ann Occup Hyg 2005; 49:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/47\">",
"      Attfield MD, Costello J. Quantitative exposure-response for silica dust and lung cancer in Vermont granite workers. Am J Ind Med 2004; 45:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/48\">",
"      Hnizdo E, Murray J. Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med 1998; 55:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/49\">",
"      Corbett EL, Churchyard GJ, Clayton T, et al. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med 1999; 159:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/50\">",
"      Sonnenberg P, Murray J, Glynn JR, et al. Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners. Eur Respir J 2000; 15:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/51\">",
"      Ross J, Ehrlich RI, Hnizdo E, et al. Excess lung function decline in gold miners following pulmonary tuberculosis. Thorax 2010; 65:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/52\">",
"      Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 2011; 54:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/53\">",
"      Saeki T, Fujita N, Kourakata H, et al. Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers. Clin Rheumatol 2004; 23:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/54\">",
"      Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure and vasculitis. Curr Opin Rheumatol 1998; 10:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/55\">",
"      Mulloy KB. Silica exposure and systemic vasculitis. Environ Health Perspect 2003; 111:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/56\">",
"      Calvert GM, Steenland K, Palu S. End-stage renal disease among silica-exposed gold miners. A new method for assessing incidence among epidemiologic cohorts. JAMA 1997; 277:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/57\">",
"      Rosenman KD, Moore-Fuller M, Reilly MJ. Kidney disease and silicosis. Nephron 2000; 85:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/58\">",
"      Hogan SL, Cooper GS, Savitz DA, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol 2007; 2:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/59\">",
"      Hertzberg VS, Rosenman KD, Reilly MJ, Rice CH. Effect of occupational silica exposure on pulmonary function. Chest 2002; 122:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/60\">",
"      Humerfelt S, Eide GE, Gulsvik A. Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years. Thorax 1998; 53:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/61\">",
"      Hnizdo E, Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med 2003; 60:237.",
"     </a>",
"    </li>",
"    <li>",
"     International Labour Office (ILO).. Guidelines for the Use of the ILO International Classification of Radiographs of Pneumoconioses, Revised Edition 2000 (Occupational Safety and Health Series, No. 22). International Labour Office, Geneva, 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/63\">",
"      Marchiori E, Ferreira A, M&uuml;ller NL. Silicoproteinosis: high-resolution CT and histologic findings. J Thorac Imaging 2001; 16:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/64\">",
"      Dee P, Suratt P, Winn W. The radiographic findings in acute silicosis. Radiology 1978; 126:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/65\">",
"      Sampson HL. The Roentgenogram in So-Called \"Acute\" Silicosis. Am J Public Health Nations Health 1933; 23:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/66\">",
"      CAPLAN A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953; 8:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/67\">",
"      Hnizdo E, Murray J, Sluis-Cremer GK, Thomas RG. Correlation between radiological and pathological diagnosis of silicosis: an autopsy population based study. Am J Ind Med 1993; 24:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/68\">",
"      Corbett EL, Murray J, Churchyard GJ, et al. Use of miniradiographs to detect silicosis. Comparison of radiological with autopsy findings. Am J Respir Crit Care Med 1999; 160:2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/69\">",
"      Talini D, Paggiaro PL, Falaschi F, et al. Chest radiography and high resolution computed tomography in the evaluation of workers exposed to silica dust: relation with functional findings. Occup Environ Med 1995; 52:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/70\">",
"      Cowie RL, Hay M, Thomas RG. Association of silicosis, lung dysfunction, and emphysema in gold miners. Thorax 1993; 48:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/71\">",
"      B&eacute;gin R, Ostiguy G, Cantin A, Bergeron D. Lung function in silica-exposed workers. A relationship to disease severity assessed by CT scan. Chest 1988; 94:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/72\">",
"      Bergin CJ, M&uuml;ller NL, Vedal S, Chan-Yeung M. CT in silicosis: correlation with plain films and pulmonary function tests. AJR Am J Roentgenol 1986; 146:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/73\">",
"      Kinsella M, M&uuml;ller N, Vedal S, et al. Emphysema in silicosis. A comparison of smokers with nonsmokers using pulmonary function testing and computed tomography. Am Rev Respir Dis 1990; 141:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/74\">",
"      Hnizdo E, Sluis-Cremer GK, Baskind E, Murray J. Emphysema and airway obstruction in non-smoking South African gold miners with long exposure to silica dust. Occup Environ Med 1994; 51:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/75\">",
"      Gevenois PA, Sergent G, De Maertelaer V, et al. Micronodules and emphysema in coal mine dust or silica exposure: relation with lung function. Eur Respir J 1998; 12:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/76\">",
"      Ooi GC, Tsang KW, Cheung TF, et al. Silicosis in 76 men: qualitative and quantitative CT evaluation--clinical-radiologic correlation study. Radiology 2003; 228:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/77\">",
"      Arakawa H, Honma K, Saito Y, et al. Pleural disease in silicosis: pleural thickening, effusion, and invagination. Radiology 2005; 236:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/78\">",
"      Ziskind M, Jones RN, Weill H. Silicosis. Am Rev Respir Dis 1976; 113:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/79\">",
"      Nugent KM, Dodson RF, Idell S, Devillier JR. The utility of bronchoalveolar lavage and transbronchial lung biopsy combined with energy-dispersive X-ray analysis in the diagnosis of silicosis. Am Rev Respir Dis 1989; 140:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/80\">",
"      Diseases associated with exposure to silica and nonfibrous silicate minerals. Silicosis and Silicate Disease Committee. Arch Pathol Lab Med 1988; 112:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/81\">",
"      Cox-Ganser JM, Burchfiel CM, Fekedulegn D, et al. Silicosis in lymph nodes: the canary in the miner? J Occup Environ Med 2009; 51:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/82\">",
"      Hoffmann EO, Lamberty J, Pizzolato P, Coover J. The ultrastructure of acute silicosis. Arch Pathol 1973; 96:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/83\">",
"      Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/84\">",
"      Cowie RL. Short course chemoprophylaxis with rifampicin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners with chronic silicosis: a double-blind placebo controlled trial. Tuber Lung Dis 1996; 77:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/85\">",
"      Morgan EJ. Silicosis and tuberculosis. Chest 1979; 75:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/86\">",
"      Lin TP, Suo J, Lee CN, et al. Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients. Am Rev Respir Dis 1987; 136:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/87\">",
"      Cowie RL. Silicotuberculosis: long-term outcome after short-course chemotherapy. Tuber Lung Dis 1995; 76:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/88\">",
"      A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Hong Kong Chest Service/tuberculosis Research Centre, Madras/British Medical Research Council. Am Rev Respir Dis 1991; 143:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/89\">",
"      Sharma SK, Pande JN, Verma K. Effect of prednisolone treatment in chronic silicosis. Am Rev Respir Dis 1991; 143:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/90\">",
"      Goodman GB, Kaplan PD, Stachura I, et al. Acute silicosis responding to corticosteroid therapy. Chest 1992; 101:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/91\">",
"      Gupta, R. Vats, M, Dadhich, P, et al. Steroid pulse therapy in silicosis. Chest 2003; 124:215S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/92\">",
"      Vermeire P, Tasson J, Lamont H, et al. Respiratory function after lung homotransplantation with a ten-month survival in man. Am Rev Respir Dis 1972; 106:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/93\">",
"      Burton CM, Milman N, Carlsen J, et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 2005; 24:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/94\">",
"      Di Giuseppe M, Gambelli F, Hoyle GW, et al. Systemic inhibition of NF-kappaB activation protects from silicosis. PLoS One 2009; 4:e5689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/95\">",
"      Mason GR, Abraham JL, Hoffman L, et al. Treatment of mixed-dust pneumoconiosis with whole lung lavage. Am Rev Respir Dis 1982; 126:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/96\">",
"      Liang ,Y, sun, U, Chen, C, et al. Clinical evaluation of massive whole lung lavage for treatment of coal workers' pneumoconiosis. He Bei Liano Yang J Hebei Convalescence 1992; 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/97\">",
"      Wilt JL, Banks DE, Weissman DN, et al. Reduction of lung dust burden in pneumoconiosis by whole-lung lavage. J Occup Environ Med 1996; 38:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/98\">",
"      Karnak D, K&ouml;yc&uuml; G, Erdemli E, et al. Acute silicoproteinosis: therapy success. Respiration 2011; 82:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/99\">",
"      KENNEDY MC. Aluminium powder inhalations in the treatment of silicosis of pottery workers and pneumoconiosis of coal-miners. Br J Ind Med 1956; 13:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/100\">",
"      Jinduo, Z, Jingde, L, Guizhi, L. Long-term follow-up observations of the therapeutic effects of PVNO. Zbl Bkt Hyg Abt Orig 1983; B178:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/101\">",
"      Dubois F, B&eacute;gin R, Cantin A, et al. Aluminum inhalation reduces silicosis in a sheep model. Am Rev Respir Dis 1988; 137:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/102\">",
"      Yu XF, Zou CQ, Lin MB. Observation of the effect of tetrandrine on experimental silicosis of rats. Ecotoxicol Environ Saf 1983; 7:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/103\">",
"      Li QL. [The therapeutic effect of tetrandrine on silicosis (author's transl)]. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi 1981; 4:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/104\">",
"      Seow WK, Ferrante A, Li SY, Thong YH. Antiphagocytic and antioxidant properties of plant alkaloid tetrandrine. Int Arch Allergy Appl Immunol 1988; 85:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/105\">",
"      B&eacute;gin R, Mass&eacute; S, Dufresne A. Further information on aluminium inhalation in silicosis. Occup Environ Med 1995; 52:778.",
"     </a>",
"    </li>",
"    <li>",
"     United States Code of Federal Regulations. Publication No. 1910.1000. U.S. Government Printing Office; Office of the Federal Register, National Archives and Records Administration, Washington, D.C, 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/107\">",
"      't Mannetje A, Steenland K, Attfield M, et al. Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts. Occup Environ Med 2002; 59:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/108\">",
"      Churchyard GJ, Ehrlich R, teWaterNaude JM, et al. Silicosis prevalence and exposure-response relations in South African goldminers. Occup Environ Med 2004; 61:811.",
"     </a>",
"    </li>",
"    <li>",
"     Criteria for a recommended standard: occupational exposure to crystalline silica. HEW Publication NpNIOSH; US Department of Health, Education and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, 1974.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33145/abstract/110\">",
"      Linch KD, Miller WE, Althouse RB, et al. Surveillance of respirable crystalline silica dust using OSHA compliance data (1979-1995). Am J Ind Med 1998; 34:547.",
"     </a>",
"    </li>",
"    <li>",
"     Wagner GR. Screening and surveillance of workers exposed to mineral dusts. World Health Organization, Geneva, 1996.",
"    </li>",
"    <li>",
"     Request for Assistance in Preventing Silicosis and Deaths in Rock Drillers, Publication No. 92-107. DHHS (NIOSH), 1992.",
"    </li>",
"    <li>",
"     Request for Assistance in Preventing Silicosis and Deaths in Construction Workers, Publication No. 96-112. 1996. 1996; (DHHSNIOSH).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4321 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-CAE323FBD7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33145=[""].join("\n");
var outline_f32_23_33145=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      FORMS OF SILICA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SILICA IN THE WORK ENVIRONMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic silicosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Accelerated silicosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Acute silicosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Associated conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chest imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Simple silicosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Progressive massive fibrosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Silicoproteinosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Experimental therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4321\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4321|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?0/51/831\" title=\"diagnostic image 1A\">",
"      Simple silicosis CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?30/57/31638\" title=\"diagnostic image 1B\">",
"      Silicosis CXR PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?8/9/8336\" title=\"diagnostic image 2\">",
"      Progressive fibrosis CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?11/32/11791\" title=\"diagnostic image 3\">",
"      Acute silicosis CXR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4321|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/47/30456\" title=\"picture 1\">",
"      Silicotic nodule pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/3/26678\" title=\"picture 2\">",
"      Silicoproteinosis pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4321|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/58/16299\" title=\"table 1\">",
"      Silicosis occupations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/20/22856?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/18/16681?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=related_link\">",
"      Asbestosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/62/8168?source=related_link\">",
"      Clinical manifestations and etiology of pulmonary alveolar proteinosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/34/14888?source=related_link\">",
"      Differential diagnosis and evaluation of multiple pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/62/5096?source=related_link\">",
"      Evaluation of diffuse lung disease by conventional chest radiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42215?source=related_link\">",
"      Long-term supplemental oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/26/424?source=related_link\">",
"      Role of lung biopsy in the diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9432?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_23_33146="Clinical features, evaluation, and treatment of retroperitoneal soft tissue sarcoma";
var content_f32_23_33146=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features, evaluation, and treatment of retroperitoneal soft tissue sarcoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     John T Mullen, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Thomas F DeLaney, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Robert Maki, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Russell S Berman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/23/33146/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/23/33146/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcomas are malignant tumors that arise from skeletal and extraskeletal connective tissues, including the peripheral nervous system. The majority of soft tissue sarcomas (STS) present in the extremities; however, many other sites can be affected, including the retroperitoneum, chest wall, head and neck, and subcutaneous tissues.",
"   </p>",
"   <p>",
"    The treatment of STS arising in the retroperitoneum will be reviewed here. A general discussion of the diagnostic evaluation and staging of STS, treatment of localized STS at other sites, local and systemic therapy for metastatic disease, treatment of desmoid tumors (which may present in intraabdominal and abdominal wall sites), and gastrointestinal stromal tumors (GIST, mesenchymal tumors that usually present in the wall of the gastrointestinal tract but occasionally present in extravisceral abdominal locations) are presented elsewhere:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227065#H12227065\">",
"       \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Introduction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38650?source=see_link\">",
"       \"Local treatment for primary soft tissue sarcoma of the extremities and chest wall\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27354?source=see_link\">",
"       \"Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/50/34602?source=see_link\">",
"       \"Head and neck sarcomas\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/3/28729?source=see_link\">",
"       \"Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/40/44680?source=see_link\">",
"       \"Surgical treatment and other localized therapy for metastatic soft tissue sarcoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/11/41146?source=see_link\">",
"       \"Systemic treatment of metastatic soft tissue sarcoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/11/30906?source=see_link\">",
"       \"Desmoid tumors: Epidemiology, risk factors, molecular pathogenesis, clinical presentation, diagnosis, and local therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35386?source=see_link\">",
"       \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retroperitoneal sarcomas are relatively uncommon, constituting only 10 to 15 percent of all STS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In a population-based series from the Surveillance, Epidemiology and End Results (SEER) database, the average annual incidence of retroperitoneal sarcomas was approximately 2.7 cases per million population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients usually present in their 50s, although the age range is broad [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The frequency is approximately equal in men and women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY, HISTOLOGY AND DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The retroperitoneum is defined anteriorly by the peritoneal extensions anchoring the transverse colon, the small bowel, and the ascending and descending colon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/7\">",
"     7",
"    </a>",
"    ]. The posterior aspect of this space is a muscular wall comprising the psoas major and minor, the quadratus lumborum, obturator internus, pyriformis muscle and the tendinous portion of the transversus abdominis muscle. The retroperitoneum is bordered superiorly by the diaphragm, inferiorly by the levator ani muscles, and laterally by the ascending and descending colon in combination with the peripheral margin of the quadratus lumborum muscles.",
"   </p>",
"   <p>",
"    Approximately 80 percent of the neoplasms that arise within the retroperitoneal space are malignant. Furthermore, the majority of patients who present with a primary retroperitoneal, extravisceral, unifocal soft tissue mass will be found to have a sarcoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Histologic types",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults, the most common histologic types of retroperitoneal STS are liposarcomas and leiomyosarcomas, followed by pleomorphic undifferentiated",
"    <span class=\"nowrap\">",
"     sarcoma/malignant",
"    </span>",
"    fibrous histiocytoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/7\">",
"     7",
"    </a>",
"    ]. A variety of other histologic types may be observed, but they are much less common in the retroperitoneum than in other primary sites. Approximately one-half of all retroperitoneal sarcomas are high-grade tumors, although this varies according to histology. The majority of retroperitoneal liposarcomas are low- to intermediate-grade lesions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227065#H12227065\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among children, the most common histologic types of retroperitoneal STS are extraskeletal Ewing",
"    <span class=\"nowrap\">",
"     sarcoma/primitive",
"    </span>",
"    neuroectodermal tumors [PNET], alveolar rhabdomyosarcoma, and fibrosarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/8\">",
"     8",
"    </a>",
"    ]. The remainder of this review will focus on the tumor types that are most common in adults. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/56/37769?source=see_link\">",
"     \"Clinical presentation, staging, and prognostic factors of the Ewing sarcoma family of tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18327?source=see_link\">",
"     \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Liposarcomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among the different variants of liposarcomas, well-differentiated (low-grade) liposarcomas are the most common, followed by dedifferentiated liposarcomas. Myxoid, round cell, and pleomorphic liposarcomas are uncommonly found in the retroperitoneum.",
"   </p>",
"   <p>",
"    Microscopically, well-differentiated liposarcomas consist of a background of adipocytes that contain scattered lipoblasts, each with a single atypical nucleus surrounded by large intracytoplasmic vacuoles. There is often an inflammatory cell infiltrate. Hypercellular well-differentiated liposarcoma may be confused with a dedifferentiated liposarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These tumors have no potential to metastasize; as such, they are referred to as atypical lipomas or atypical lipomatous tumors when they arise in the extremity or body wall. However, given their propensity for local recurrence in the retroperitoneum, these same tumors are referred to as well-differentiated liposarcomas in this location.",
"   </p>",
"   <p>",
"    Dedifferentiated liposarcomas are defined by the presence of sharply demarcated regions of non-lipogenic sarcomatous tissue within a well-differentiated tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/7\">",
"     7",
"    </a>",
"    ]. They may be difficult to distinguish from pleomorphic undifferentiated sarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/10-13\">",
"     10-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Well-differentiated and dedifferentiated liposarcomas have morphologic and cytogenetic similarities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/14\">",
"     14",
"    </a>",
"    ] but significantly different biologic behavior. Dedifferentiated liposarcomas are high-grade tumors. Compared to well-differentiated low-grade liposarcomas, they have higher local recurrence rates, the potential to metastasize (20 to 30 percent distant recurrence rate versus 0 percent for well-differentiated liposarcomas), and a six-fold higher risk of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. It is thought that high-grade, dedifferentiated liposarcomas arise from well-differentiated liposarcomas, and that well-differentiated liposarcomas can recur as the more aggressive, dedifferentiated subtype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Leiomyosarcomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leiomyosarcomas of the retroperitoneum generally arise from the inferior vena cava, its branches, or any small vessel. They often present as a mass or, occasionally, with unilateral or bilateral leg swelling, and they are usually of a large size when diagnosed.",
"   </p>",
"   <p>",
"    The clinical issues presented by a large leiomyosarcoma differ from those of a",
"    <span class=\"nowrap\">",
"     well-differentiated/dedifferentiated",
"    </span>",
"    liposarcoma. Lung (more than liver) metastases are sometimes observed at the time of presentation or appear relatively quickly after diagnosis. Leiomyosarcomas may also arise from the wall of the GI tract or from the uterus. In this situation they are visceral rather than retroperitoneal, and they have a greater risk of peritoneal spread and metastases to liver. For these reasons, follow-up after complete resection of a leiomyosarcoma of the abdomen or retroperitoneum should involve imaging of the chest as well as of the abdomen and pelvis on a regular schedule, as noted for other retroperitoneal sarcomas. (See",
"    <a class=\"local\" href=\"#H35\">",
"     'Posttreatment follow-up'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, lymphoma, a primary germ cell tumor, or metastatic testicular cancer presents as a retroperitoneal mass. Neoplasms originating in the duodenum, pancreas, adrenal, or kidney can usually be distinguished from an extravisceral retroperitoneal soft tissue mass based upon the radiographic appearance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41720?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=see_link\">",
"     \"Extragonadal germ cell tumors involving the mediastinum and retroperitoneum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other benign and malignant tumors, such as schwannomas and paragangliomas, should be considered in the differential diagnosis of a retroperitoneal mass, particularly one located in the midline adjacent to the aorta or vena cava.",
"   </p>",
"   <p>",
"    Two typically benign processes, Castleman's disease (angiofollicular lymph node hyperplasia), and retroperitoneal fibrosis, arise within the retroperitoneum, and can mimic a STS, both clinically and radiographically. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=see_link\">",
"     \"Castleman's disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34136?source=see_link\">",
"     \"Clinical manifestations and diagnosis of retroperitoneal fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retroperitoneal STS typically produce few symptoms until they are large enough to compress or invade surrounding structures. Most cases come to medical attention as an incidentally discovered abdominal mass in an asymptomatic or minimally symptomatic patient. Most tumors are already large and locally advanced at the time they are first detected (median size at diagnosis is approximately 15 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4\">",
"     4",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    Some patients present with pain, or signs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    symptoms that are related to mass effect of the tumor on surrounding structures. Local invasion or compression of retroperitoneal neurovascular structures can result in lower extremity edema and neurologic or musculoskeletal symptoms that may be referred to the lower extremities. Gastrointestinal symptoms such as early satiety, obstruction,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bleeding can also occur.",
"   </p>",
"   <p>",
"    Serous ascites due to portal vein compression has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Rarely, patients with high-grade rapidly expanding tumors may experience flu-like symptoms, and present with fevers and leukocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/17,19\">",
"     17,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rarely, leiomyosarcomas present with paraneoplastic hypoglycemia that is usually secondary to tumor production of \"big\" insulin-like growth factor-II [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/17,18,20\">",
"     17,18,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11461?source=see_link\">",
"     \"Nonislet cell tumor hypoglycemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Distant metastases (most commonly to lung and liver) are present at the time of diagnosis in approximately 10 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION AND STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given that lymphoma and germ cell tumors may occasionally present as a retroperitoneal mass, the initial history should always include questions as to symptoms related to lymphoma (eg, fever, night sweats, weight loss). The physical examination should include palpation of all nodal basins and, in men, a careful testicular examination. A normal testicular exam does not exclude the diagnosis of testicular cancer metastatic to the retroperitoneal nodes; thus, an ultrasound of the testicles should be strongly considered in the evaluation of a young man with a newly diagnosed retroperitoneal mass.",
"   </p>",
"   <p>",
"    Laboratory studies should include measurement of lactate dehydrogenase (an elevated level may be suggestive of lymphoma), alpha-fetoprotein, and beta-human chorionic gonadotropin (which, if elevated, raises the suspicion for a germ cell tumor).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radiographic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic imaging is a key component of the evaluation of a patient with a retroperitoneal mass. The preferred diagnostic study is a CT scan of the abdomen and pelvis to evaluate the primary site, as well as a chest CT to rule out metastatic disease to the lungs. The lungs are the first site of metastasis in the majority of cases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227107#H12227107\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Pattern of spread'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI rarely adds important information. In most cases, CT is less sensitive to motion artifact than MRI, and it better defines the anatomic relationship of the tumor to other abdominal organs. It can also detect metastases to the liver or peritoneum. The radiographic appearance of the primary tumor on CT scan can also offer clues as to the histologic subtype and grade, which may guide decisions as to the need for a pretreatment biopsy as well as treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227156#H12227156\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'MRI and CT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Need for biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A biopsy is indicated if the diagnosis is in doubt. However, when the diagnosis seems straightforward (eg, if the CT reveals a homogeneous, fat-density, retroperitoneal mass with the typical radiographic appearance of a well-differentiated liposarcoma), preoperative tissue diagnosis is not necessary if surgery is planned to be the primary therapeutic intervention. On the other hand, percutaneous core needle biopsy can provide a tissue diagnosis for a locally advanced, unresectable lesion, or if there is radiographic suspicion of areas of dedifferentiation (eg, focal",
"    <span class=\"nowrap\">",
"     nodular/water",
"    </span>",
"    density areas within an otherwise fat-containing retroperitoneal mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/22\">",
"     22",
"    </a>",
"    ]), which may prompt consideration for preoperative RT. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Preoperative RT'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In general, clinicians should have a low threshold to proceed with a percutaneous core needle biopsy, as the very small risk of complications and the unsubstantiated fear of tumor seeding of the biopsy tract are far outweighed by the information obtained from the biopsy in terms of developing a rational treatment approach to the patient, which may entail referral to a center specializing in the treatment of the given tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Criteria for unresectability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic findings that indicate unresectability include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extensive vascular involvement (aorta, vena cava",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      iliac vessels), although involvement of the vena cava and iliac veins is a relative rather than absolute contraindication, as these vessels can often be ligated or replaced with interposition grafts",
"     </li>",
"     <li>",
"      Peritoneal implants",
"     </li>",
"     <li>",
"      Distant metastases",
"     </li>",
"     <li>",
"      Involvement of the root of the mesentery (specifically, the superior mesenteric vessels)",
"     </li>",
"     <li>",
"      Spinal cord involvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retroperitoneal sarcomas are staged using the same TNM system as is used for extremity STS (",
"    <a class=\"graphic graphic_table graphicRef66617 \" href=\"mobipreview.htm?23/13/23773\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/24\">",
"     24",
"    </a>",
"    ]. However, the ability of the TNM staging system to discriminate outcomes is limited. Several studies have found no prognostic role for tumor size in retroperitoneal sarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4,5,10,11,25-27\">",
"     4,5,10,11,25-27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H351701269#H351701269\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the importance of histologic grade and resection margins in the prognosis of retroperitoneal STS, an alternative staging system has been proposed that incorporates these features as well as the presence or absence of metastatic disease (",
"    <a class=\"graphic graphic_table graphicRef61503 \" href=\"mobipreview.htm?8/32/8715\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/27\">",
"     27",
"    </a>",
"    ]. However, this staging system is not in widespread use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the rarity of these tumors and the complexity of treatment, evaluation and management should ideally be carried out in a center with multidisciplinary expertise in the treatment of sarcomas. The multidisciplinary team approach by dedicated subspecialists optimizes treatment planning, minimizes the duplication of diagnostic studies, reduces the time to implementation of the definitive therapeutic protocol, and improves clinical outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Surgical resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical resection has traditionally been the only potentially curative treatment for a localized retroperitoneal STS. The ability to perform a complete surgical resection at the time of initial presentation is the most important prognostic factor for survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4,6,17,28-33\">",
"     4,6,17,28-33",
"    </a>",
"    ]. The usual reasons for unresectability are extensive vascular involvement or the presence of multiple peritoneal implants.",
"   </p>",
"   <p>",
"    The primary oncologic goal is complete resection with microscopically negative margins (R0 resection). However, the large size of most retroperitoneal tumors, coupled with the inability to obtain wide margins due to anatomic constraints make this goal difficult to achieve. In clinical practice, many resections are grossly complete but with microscopically positive margins (R1 resection, termed a \"complete resection\" in many literature reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]). In a review of four large series of patients with retroperitoneal sarcoma from institutions with extensive experience in management of this disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4-6,34\">",
"     4-6,34",
"    </a>",
"    ], complete resection rates were between 50 and 67 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/35\">",
"     35",
"    </a>",
"    ]. In the largest of these series, the \"complete\" (R0 plus R1) and R0 resection rates were 80 and 58 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/6\">",
"     6",
"    </a>",
"    ]. The implications and management of a microscopically positive margin are discussed below. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Management of microscopically positive margins'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Resection of adjacent organs such as the small bowel, colon or kidney is often required to achieve a complete resection and bowel preparation and evaluation of kidney function should be performed prior to exploration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/18,36\">",
"     18,36",
"    </a>",
"    ]. Liberal en-bloc resection of adjacent viscera may allow a subset of patients to achieve wide, macroscopically negative surgical margins who might otherwise have been considered unresectable. Although this practice results in lower rates of microscopically positive margins and better local control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4,5,37-39\">",
"     4,5,37-39",
"    </a>",
"    ], it is not clear that additional resection will translate into improvements in sarcoma-specific survival, or whether this approach is preferred over preoperative RT followed by surgery (see below).",
"   </p>",
"   <p>",
"    The most common organs removed, in order of frequency, are kidney, colon, spleen, and pancreas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/5\">",
"     5",
"    </a>",
"    ]. Despite the frequent need for nephrectomy, true parenchymal invasion of the kidney is uncommon (eg, invasion of the kidney parenchyma occurred in only two of 30 nephrectomies in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/23\">",
"     23",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    The same surgical considerations apply to retroperitoneal sarcomas that involve or originate from major blood vessels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/40\">",
"     40",
"    </a>",
"    ]. Involvement of vascular structures is common. In one series, 24 of 141 patients with retroperitoneal STS had major blood vessel involvement at diagnosis, and underwent aggressive surgery, including resection and reconstruction of a major blood vessel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/40\">",
"     40",
"    </a>",
"    ]. The perioperative mortality rate was 4 percent, and the five-year overall survival rate was 66 percent.",
"   </p>",
"   <p>",
"    For leiomyosarcomas arising in the inferior vena cava, the need for postresection vascular reconstruction is debated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. Below the renal veins, the vena cava can often be ligated with impunity, as many of these patients have developed an extensive collateral circulation and stable lower extremity edema as a result of chronic caval obstruction by the tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Role of debulking surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no survival benefit for incomplete resection (a \"debulking\" procedure) in patients with unresectable retroperitoneal STS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/18,35\">",
"     18,35",
"    </a>",
"    ]. In a review of the largest retrospective series from four expert institutions, the median survival for patients undergoing incomplete resection was not significantly better than for those with categorically unresectable disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, in select patients with unresectable retroperitoneal liposarcoma, incomplete surgical resection can result in prolonged survival (median survival 26 versus 4 months in one retrospective series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/44\">",
"     44",
"    </a>",
"    ]) as well as palliation of symptoms when compared to patients who are not resected at all. The patients most likely to benefit from this approach are those presenting with primary rather than locally recurrent tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Role of intraoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonrandomized studies of IORT in patients undergoing surgery for retroperitoneal STS suggest high rates of recurrence-free and overall survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/45-49\">",
"     45-49",
"    </a>",
"    ]. A single prospective trial has been completed, in which patients with completely resected retroperitoneal STS were randomly assigned to postoperative high-dose RT (50 to 55 Gy) alone or IORT (20 Gy) in combination with low-dose postoperative EBRT (35 to 40 Gy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The median survival time was similar in the two groups (45 versus 52 months). The use of IORT was associated with a significantly fewer locoregional recurrences (6 of 15 [40 percent] versus 16 of 20 [80 percent]) and fewer complications of disabling enteritis (2 of 15 versus 10 of 20), but a higher frequency of radiation-related peripheral neuropathy (9 of 15 versus 1 of 20).",
"   </p>",
"   <p>",
"    At our institution, we have employed a treatment policy of preoperative RT, resection, and an IORT boost for retroperitoneal STS since 1982. The latest update of our experience included 37 patients with primary or recurrent retroperitoneal STS; 20 who received preoperative RT (median dose 45 Gy) followed by resection and IORT, and a nonrandomized group of 17 patients who underwent preoperative RT followed by attempted resection without IORT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/49\">",
"     49",
"    </a>",
"    ]. Gross total resection was possible in 29 patients, 16 of whom also received IORT.",
"   </p>",
"   <p>",
"    The five-year actuarial overall and disease-free survival and local control rates for all 37 patients were 50, 38, and 59 percent, respectively. When the 29 completely resected patients were considered, patients receiving IORT as a component of therapy had a significantly better overall survival (74 versus 30 percent) and local control rate (83 percent versus 61 percent) than did those not undergoing IORT. Complications, which were seen in 4 of 20 patients receiving IORT, included three patients with neuropathy and three ureteral injuries. These findings suggest that care must be taken if these structures are in the intraoperative radiation treatment volume.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Management of microscopically positive margins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopically positive margins increase the risk for local recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30,32,51\">",
"     30,32,51",
"    </a>",
"    ], but whether they adversely influence survival is less clear. In some series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30,31,51\">",
"     30,31,51",
"    </a>",
"    ], patients who have an R1 resection have higher rates of distant recurrence and inferior survival as compared to those undergoing R0 (microscopically-negative) resections, but others have failed to show a relationship between microscopically positive margins and inferior survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/16,52\">",
"     16,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, M. D. Anderson reviewed their experience in 666 patients who had a macroscopic (R0 or R1) resection for STS, 24 originating in the retroperitoneum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/52\">",
"     52",
"    </a>",
"    ]. Within the entire cohort, those who underwent reresection followed by RT had significantly higher rates of local recurrence-free survival (RFS, 85 versus 78 percent), distant RFS (81 versus 69 percent) and disease-specific survival (83 versus 73 percent) than did those who underwent postoperative irradiation without reresection. When the analysis was limited to patients with retroperitoneal STS, the same local recurrence effect was seen, but there was no significant impact of the positive margins on either distant recurrence or survival.",
"   </p>",
"   <p>",
"    Following an R1 or R2 resection, reresection of the tumor bed is preferred, if feasible, but this is often not possible, as the residual microscopic or macroscopic tumor frequently abuts structures or organs that cannot be easily or safely resected. For these patients, and for those who refuse further surgery, postoperative RT can provide local tumor control and the opportunity for long-term relapse-free survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/2,53\">",
"     2,53",
"    </a>",
"    ]. If the surgeon anticipates an R1 or R2 resection intraoperatively, clips should be placed within high-risk areas for recurrence so that these sites can be boosted to higher RT dose levels postoperatively. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Adjuvant RT'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Adjunctive RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to extremity STS in which the most common site of first recurrence is a distant site, the primary pattern of treatment failure after resection of a retroperitoneal STS is local. Five-year local recurrence rates after a complete resection of a retroperitoneal STS are between 41 and 50 percent, and local recurrence is the site of first failure in 90 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/26\">",
"     26",
"    </a>",
"    ]. These high relapse rates have prompted investigation of combined modality treatment approaches. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Outcomes and prognostic factors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Adjunctive radiation therapy (RT) can be administered following resection (adjuvant RT). However, increasingly, preoperative RT is being chosen for large high-grade or intermediate-grade STS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Adjuvant RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials of surgery with and without postoperative (adjuvant) external beam RT (EBRT). In retrospective uncontrolled series, the addition of postoperative RT reduces the risk of local recurrence and lengthens the recurrence-free interval; there has been no suggestion of a survival benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4,26,29,35,38,53-56\">",
"     4,26,29,35,38,53-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest uncontrolled study included 145 French patients who presented with a localized retroperitoneal sarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4\">",
"     4",
"    </a>",
"    ]. The median tumor size was 15 cm (range 2 to 70 cm), 31 percent presented with neurovascular or bone involvement, 39 percent had grade 3 lesions, and 30 percent had liposarcoma subtype. Complete (macroscopic) excision had been carried out in 94, and 60 of these patients received postoperative RT (median dose 50 Gy).",
"   </p>",
"   <p>",
"    Among patients who underwent complete excision, the five-year actuarial local recurrence-free survival was significantly greater for the 60 irradiated patients compared to the 34 who did not receive it (55 versus 23 percent). The toxicities of postoperative RT were not reported.",
"   </p>",
"   <p>",
"    It is often difficult to deliver postoperative radiation therapy because the bowel and other organs fall into the resection cavity; however, newer techniques such as intensity-modulated RT (IMRT) and proton beam irradiation make it more feasible but the therapeutic ratio is probably still more favorable with preoperative RT. Nevertheless, it is reasonable to consider the use of postoperative RT if it can be delivered safely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Preoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the postoperative setting, radiation doses to the tumor bed are often limited by the large field size and the proximity and tolerance of surrounding radiosensitive normal structures, such as the liver and bowel. In fact, many multidisciplinary sarcoma groups do not routinely offer postoperative RT to patients with resected retroperitoneal sarcomas because of significant concerns about the narrow therapeutic ratio.",
"   </p>",
"   <p>",
"    The delivery of RT prior to surgery, with or without intraoperative RT (IORT) at the time of resection, may permit the safe delivery of higher RT doses than are possible in the postoperative setting, as has been shown for extremity sarcomas.",
"   </p>",
"   <p>",
"    There are several theoretical advantages for preoperative as compared to postoperative RT for retroperitoneal STS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The main advantage of preoperative RT is that the gross tumor volume can be precisely defined for radiation treatment planning, allowing accurate targeting of the radiation volume around the tumor.",
"     </li>",
"     <li>",
"      The tumor itself can act to displace small bowel from the high-dose radiation treatment volume, resulting in safer and less toxic treatment.",
"     </li>",
"     <li>",
"      Higher RT doses can be delivered to the actual tumor field, since bowel adhesions to tumor are less likely compared to the postoperative setting.",
"     </li>",
"     <li>",
"      The risk of intraperitoneal tumor dissemination at the time of the operation may be reduced by preoperative RT.",
"     </li>",
"     <li>",
"      Radiation is considered to be biologically more effective in the preoperative setting.",
"     </li>",
"     <li>",
"      It is possible that an initially unresectable tumor may be converted to one that is potentially resectable for cure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/41,59\">",
"       41,59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These advantages may result in an improvement in the therapeutic ratio when RT is administered preoperatively.",
"   </p>",
"   <p>",
"    The benefits (similar tumor control and a lower incidence of late, irreversible side effects) of preoperative as compared to postoperative RT in extremity and chest wall STS have been demonstrated in a randomized trial. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38650?source=see_link&amp;anchor=H10#H10\">",
"     \"Local treatment for primary soft tissue sarcoma of the extremities and chest wall\", section on 'Preoperative versus postoperative RT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Randomized trials of resection with and without preoperative RT are not available for retroperitoneal STS. Early results of retrospective single institution reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/41,45,49,60,61\">",
"     41,45,49,60,61",
"    </a>",
"    ] and prospective, nonrandomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/55,62,63\">",
"     55,62,63",
"    </a>",
"    ] evaluating preoperative RT in this setting are available.",
"   </p>",
"   <p>",
"    The prospective studies from Princess Margaret Hospital (PMH) and M. D. Anderson Cancer Center (MDACC) are informative because the acute toxicities of preoperative radiation were prospectively recorded separately from other toxicities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/55,62,63\">",
"     55,62,63",
"    </a>",
"    ]. By contrast, in two of the four retrospective series, preoperative RT and IORT were both administered, and the toxicity reports represent a combined effect of both treatment modalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/45,49\">",
"     45,49",
"    </a>",
"    ]. These studies are discussed below. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Role of intraoperative RT'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Investigators at the PMH prospectively treated 41 patients with preoperative RT (median dose 45 Gy) combined with a postoperative brachytherapy boost (median dose 25 Gy) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/55\">",
"       55",
"      </a>",
"      ]. Although the median radiation volume was relatively large, the",
"      <span class=\"nowrap\">",
"       EORTC/RTOG",
"      </span>",
"      acute radiation toxicity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/64\">",
"       64",
"      </a>",
"      ] scores were &le;2 (ie, no worse than tender or bright erythema, patchy moist",
"      <span class=\"nowrap\">",
"       desquamation/moderate",
"      </span>",
"      edema) in all patients who underwent resection. Furthermore, no patient was hospitalized for acute toxicity, and there were no treatment interruptions or requirements for cessation of treatment because of acute toxicity.",
"      <br/>",
"      <br/>",
"      Postoperative brachytherapy to the upper abdomen was associated with substantial toxicity (eg, duodenitis and gastric outlet obstruction), prompting investigators to limit subsequent use of brachytherapy to the lower abdomen. The two-year overall and disease-free survival rates for patients with resected retroperitoneal STS were 88 and 80 percent, respectively.",
"     </li>",
"     <li>",
"      Long-term results of preoperative RT are available in a combined report of the experience from PMH and MDACC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/63\">",
"       63",
"      </a>",
"      ]. For the 54 patients with primary retroperitoneal STS who underwent macroscopically complete (ie, R0 or R1) resection after preoperative RT, the five-year local recurrence-free, disease-free, and overall survival rates were 60, 46, and 61 percent, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Due to the complexity of treatment, preoperative RT should only be carried out in a center with expertise in the treatment of sarcomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Preoperative IMRT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intensity-modulated RT (IMRT) has the potential to further improve the therapeutic index by permitting dose escalation to the area of the tumor while minimizing the dose to normal tissues at risk for radiation toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. An innovative strategy combines IMRT with a novel target volume concept for the preoperative treatment of retroperitoneal STS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/65\">",
"     65",
"    </a>",
"    ]. IMRT was used to deliver RT (50 Gy in 25 daily 2 Gy fractions) to a preoperative clinical target volume that was limited to the contact area between the tumor mass and the posterior abdominal wall. All 18 patients completed the planned treatment with acceptable acute toxicity and underwent successful resection without major complications. With early follow-up (median 27 months), only two patients failed locally and one developed distant metastases.",
"   </p>",
"   <p>",
"    The authors concluded that this strategy was feasible, well tolerated, and associated with better radiation sparing of critical structures, without compromising the rate of resectability. Longer follow-up is needed to assess the ultimate impact on local control and survival.",
"   </p>",
"   <p>",
"    Tzeng et al were able to perform selective preoperative radiation dose escalation to the retroperitoneal margin of a retroperitoneal sarcoma in 16 patients using IMRT to deliver 45 Gy in 25 fractions (1.8 Gy per fraction) to the entire tumor, and 57.5 Gy in 25 fractions (2.3 Gy per fraction) to the boosted retroperitoneal margin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/58\">",
"     58",
"    </a>",
"    ]. Treatment morbidity was acceptable and the actuarial two-year local control rate was 80 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Preoperative chemoradiotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concurrent administration of preoperative RT and chemotherapy (chemoradiotherapy) is used in some patients with large high-grade or locally recurrent extremity STS, particularly if limb salvage is an issue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38650?source=see_link&amp;anchor=H12#H12\">",
"     \"Local treatment for primary soft tissue sarcoma of the extremities and chest wall\", section on 'Initial chemoradiotherapy for large high-grade STS'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27354?source=see_link&amp;anchor=H5#H5\">",
"     \"Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities\", section on 'Preoperative chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is increasing interest in this approach for retroperitoneal STS. Although randomized trials are not available, at least two small studies showed that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    -based chemoradiotherapy is feasible and safe in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/62,68\">",
"     62,68",
"    </a>",
"    ]. In one of these reports, 6 of 23 patients treated preoperatively with doxorubicin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    plus concurrent RT (28 Gy) had a complete pathologic response (ie, no residual tumor at exploration) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The second report was a phase I study of weekly",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    for four to five weeks (4",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    as an initial bolus once weekly, followed by a four day continuous infusion of 4",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    per day with concurrent EBRT in escalating doses) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/62\">",
"     62",
"    </a>",
"    ]. Four to eight weeks after chemoradiotherapy, radiographic restaging was performed and patients with localized disease underwent resection and IORT.",
"   </p>",
"   <p>",
"    Chemoradiotherapy was successfully completed by all 35 patients, with four requiring hospital admission during or in the immediate postchemoradiotherapy period. At the highest RT doses (50.4 Gy), there were two patients with grade 3 or 4 nausea; otherwise, treatment was well tolerated. A grossly complete tumor resection (R0 or R1) was possible in 26 of the 29 patients who had surgery; interval progression precluded surgery in six patients. Long-term outcomes were not reported.",
"   </p>",
"   <p>",
"    Although these results seem promising, questions remain as to whether any combined chemoradiotherapy approach is more effective than preoperative RT alone. The lack of data from prospective trials is a major hindrance to progress in this field. In 2003, the Radiation Therapy Oncology Group (RTOG) initiated a multicenter phase II trial of preoperative combined modality therapy (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    plus EBRT) followed by resection with an intraoperative or postoperative RT boost for intermediate or high-grade primary or recurrent retroperitoneal STS. Unfortunately, the trial was closed because of poor patient accrual. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27354?source=see_link&amp;anchor=H5#H5\">",
"     \"Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities\", section on 'Preoperative chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Preoperative chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited, neoadjuvant (preoperative) chemotherapy appears to be safe and occasionally induces a radiographic response, which may impact surgical therapy in a few patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/69-72\">",
"     69-72",
"    </a>",
"    ]. Although responders tend to do better than nonresponders, whether this reflects an impact of chemotherapy, disease biology, or patient selection remains uncertain.",
"   </p>",
"   <p>",
"    If this approach is chosen, the optimal regimen has not been established. However, in keeping with guidelines for extremity sarcoma in the adjuvant setting, regimens that contain",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    are probably most effective, particularly for patients with leiomyosarcoma. Given the low response rate of",
"    <span class=\"nowrap\">",
"     well-differentiated/dedifferentiated",
"    </span>",
"    liposarcomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/73\">",
"     73",
"    </a>",
"    ], neoadjuvant chemotherapy cannot be recommended routinely. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/11/14521?source=see_link\">",
"     \"Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Systemic chemotherapy with regional hyperthermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least some data from Europe suggest that systemic chemotherapy combined with regional hyperthermia may represent an alternative treatment technique for patients with locally advanced unresectable high-grade STS of the extremities and trunk, as well as those with a locally recurrent tumor in an irradiated field [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/45-47,49\">",
"     45-47,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Benefit for this approach was suggested in a trial (EORTC study 62961) in which 341 patients with locally recurrent (n = 37), incompletely resected or resected with a surgical margin &lt;1 cm (n = 142), or grade 2 or 3 primary STS &ge;5 cm (n = 162) of the extremity (43 percent) or non-extremity site (56 percent, with the majority in the pelvis or abdomen) were randomly assigned to four courses of systemic chemotherapy with or without regional hyperthermia, followed by aggressive local therapy (surgery",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    RT) and four additional courses of chemotherapy with or without regional hyperthermia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/74\">",
"     74",
"    </a>",
"    ]. Chemotherapy consisted of 21-day cycles of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    (125",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    on days 1 and 4),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    (1500",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    per day on days 1 through 4), and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    (50",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    on day 1 only), while regional hyperthermia was performed by exposing the affected body part to temperatures between 40 and 43 degrees for 60 minutes on days 1 and 4 of each chemotherapy course.",
"   </p>",
"   <p>",
"    The objective response rate from preoperative chemotherapy was significantly higher in the hyperthermia group (29 versus 13 percent), although the number of patients who had definitive tumor resection as a component of local treatment was similar (two-thirds of both groups). At a median follow-up of 34 months, disease-free survival (median 32 versus 18 months), and two-year local progression-free survival (76 versus 61 percent) significantly favored the regional hyperthermia arm. In subset analysis, the higher rate of two-year local progression-free survival with hyperthermia was statistically significant in those with non-extremity sarcomas (64 versus 45 percent, p = 0.012) but not in those with an extremity sarcoma (92 versus 80 percent).",
"   </p>",
"   <p>",
"    Overall survival was not significantly better in the hyperthermia group when all patients were analyzed (at four years, 59 versus 57 percent), but in the 269 patients who completed the full treatment, those who received hyperthermia were 44 percent less likely to die during follow-up that those assigned to chemotherapy alone.",
"   </p>",
"   <p>",
"    Although not used much in the US, regional hyperthermia with systemic chemotherapy is an option for high-risk tumors in parts of the world where it is available (mainly Germany). Whether this approach is superior to surgery alone or with RT will require a randomized trial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of adjuvant chemotherapy following surgical resection of a soft tissue sarcoma (STS) at any site is controversial. Multiple randomized trials have been undertaken, with disparate results. An updated meta-analysis suggested that use of an optimal, adequately dosed",
"    <span class=\"nowrap\">",
"     anthracycline/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/25/38297?source=see_link\">",
"      ifosfamide",
"     </a>",
"     -containing",
"    </span>",
"    regimen significantly prolongs survival, but the analysis did not include the two largest trials, both conducted in Europe and both testing the value of an anthracycline and ifosfamide-containing regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/75\">",
"     75",
"    </a>",
"    ]. A preliminary report of a pooled analysis of both trials indicated no benefit from this approach. Thus, adjuvant chemotherapy cannot be considered a standard approach for a STS at any site.",
"   </p>",
"   <p>",
"    Adjuvant chemotherapy in the management of soft tissue sarcomas is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/11/14521?source=see_link\">",
"     \"Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Outcomes and prognostic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retroperitoneal sarcomas have a substantially less satisfactory outcome than soft tissue sarcomas (STS) at other sites, such as the extremities or trunk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4-6,28,29,35,52,60,76\">",
"     4-6,28,29,35,52,60,76",
"    </a>",
"    ]. Several factors contribute to poor outcome and a high rate of recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/76\">",
"     76",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Retroperitoneal STS are often large at diagnosis and anatomically situated such that wide resection is often not achievable.",
"     </li>",
"     <li>",
"      Even with complete resection, retroperitoneal liposarcomas tend to do worse than extremity liposarcomas, independent of tumor size, grade, or surgical margin.",
"     </li>",
"     <li>",
"      The surrounding normal tissues (liver, kidney, gastrointestinal tract, spinal cord) have relatively low tolerance for radiation therapy (RT). As a result, radiation dose levels must be kept below those typically employed for extremity sarcomas.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast to extremity sarcomas, 90 percent of first recurrences are local [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/26\">",
"     26",
"    </a>",
"    ]. Eventually, distant metastases develop in 20 to 30 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/21,35\">",
"     21,35",
"    </a>",
"    ]. The main sites of distant metastases are liver and lungs.",
"   </p>",
"   <p>",
"    Local recurrence rates are higher with high-grade (poorly differentiated) tumors, liposarcoma histology, and in patients with positive resection margins. Recurrences may be delayed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local control rates range from 41 to 55 percent at five years, but are only 18 to 40 percent at 10 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/21,26,29,77\">",
"       21,26,29,77",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 198 adult patients with retroperitoneal soft tissue sarcoma who were eligible for &ge;5 years of follow-up, 40 percent of patients who were alive and disease-free at five years recurred by 10 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, long-term follow-up is mandatory. (See",
"    <a class=\"local\" href=\"#H35\">",
"     'Posttreatment follow-up'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Five-year overall survival rates range from 36 to 63 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4-6,16,18,29,77-79\">",
"     4-6,16,18,29,77-79",
"    </a>",
"    ]. The most important predictive factor for survival is tumor resectability, as illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In two surgical series in which the resectability rate was 50 percent or less, five-year survival rates were 20 and 36 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/29,80\">",
"       29,80",
"      </a>",
"      ]. In one of these series, only 14 percent of patients were still alive at ten years, and only 9 percent remained free of a locoregional recurrence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, those series reporting high rates of surgical resectability have better survival and fewer local recurrences [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4,6,30,34,77,81-83\">",
"       4,6,30,34,77,81-83",
"      </a>",
"      ]. As an example, in a series of 87 consecutive patients undergoing complete resection for retroperitoneal sarcoma at a single institution, the five-year local recurrence rate was 25 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/77\">",
"       77",
"      </a>",
"      ]. Survival rates at five and ten years were 66 and 57 percent, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The next most important prognostic factor is histologic grade of differentiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/11,25,84\">",
"     11,25,84",
"    </a>",
"    ]. In a single-center series of 183 patients with truncal or retroperitoneal STS,",
"    <span class=\"nowrap\">",
"     high/intermediate-grade",
"    </span>",
"    histology was associated with a five- to sixfold increased risk of death compared to low-grade differentiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Others emphasize the importance of histologic subtype, with well-differentiated liposarcomas having the most favorable, and leiomyosarcomas, pleomorphic",
"    <span class=\"nowrap\">",
"     sarcoma/MFH,",
"    </span>",
"    MPNST and dedifferentiated liposarcomas the least favorable outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/10,11,16,21,84-87\">",
"     10,11,16,21,84-87",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227219#H12227219\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Prognostic factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nomograms have been developed and validated to more accurately predict postoperative survival based upon these and other features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/84,86,88-90\">",
"     84,86,88-90",
"    </a>",
"    ]. None of the site-specific nomograms are available online. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227240#H12227240\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Prognostic tools'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Summary and recommendations from expert groups",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical resection has traditionally been the only potentially curative approach for a localized, potentially resectable retroperitoneal sarcoma. Because of the typically large size and anatomic complexity of these tumors at diagnosis, a complete resection with microscopically negative margins (R0 resection) is often not achieved, and locoregional recurrence is common.",
"   </p>",
"   <p>",
"    For patients with potentially resectable, low-grade retroperitoneal sarcomas, we suggest initial surgery. For patients with initially unresectable or borderline resectable low-grade tumors and all intermediate-grade and high-grade retroperitoneal sarcomas, we suggest enrollment in a clinical trial. For those not protocol-eligible, or for whom protocol treatment is not feasible, we suggest preoperative RT (45 Gy at 1.8 Gy per fraction over a total time of five weeks), a rest period of approximately four to six weeks, followed by surgical resection and intraoperative radiation therapy (IORT, 10 to 12 Gy as a single dose to the resection bed). If IORT is not available, we still recommend preoperative radiation with consideration of dose escalated RT to the retroperitoneal margin using intensity-modulated RT (IMRT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Preoperative IMRT'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If the patient is seen following resection of a retroperitoneal STS, we do not suggest adjuvant RT for a low-grade, completely resected (margin-negative) tumor. For all other patients, we recommend consideration of postoperative radiation if this can be done within the tolerance of the adjacent normal tissues. IMRT or proton-beam irradiation may allow this to be done with acceptable morbidity.",
"   </p>",
"   <p>",
"    For patients who are left with gross residual disease, we attempt to administer a postoperative, small-field supplemental boost dose or intraoperative radiation to areas of grossly evident disease.",
"   </p>",
"   <p>",
"    Consensus-based guidelines for management of retroperitoneal sarcoma from the National Comprehensive Cancer Network (NCCN) include the following",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN guidelines",
"    </a>",
"    :",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For potentially resectable tumors, surgery or preoperative RT or preoperative chemotherapy are options. If an initial nonsurgical approach is chosen, pretreatment biopsy is suggested.",
"     </li>",
"     <li>",
"      For resected tumors, the guidelines suggest that postoperative RT be &ldquo;considered&rdquo; in highly selected patients following a microscopically complete (R0) resection, for example those with high grade or extremely large tumors, a critical anatomic location where recurrence would cause morbidity, or close margins. For patients undergoing a macroscopically complete (R1) resection, they suggest consideration of postoperative RT in patients who did not receive preoperative RT, or a postoperative boost of 10 to 16 Gy if preoperative RT was given.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, consensus-based guidelines from the European Society of Medical Oncology (ESMO) consider that the value of preoperative treatments in potentially resectable retroperitoneal sarcomas is not established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/91\">",
"     91",
"    </a>",
"    ]. For resected tumors, they state that postoperative RT may be an option in well-defined areas felt to be at high risk for a local recurrence. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF LOCAL RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local recurrence after complete resection of a primary retroperitoneal sarcoma is relatively common. The factors that determine the frequency of local recurrence include histologic subtype and grade, status of the surgical margins, and whether adjunctive RT was administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Outcomes and prognostic factors'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H19\">",
"     'Adjunctive RT'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reresection should be considered for an isolated, locally recurrent tumor; approximately 60 percent of such tumors are potentially resectable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30,92\">",
"     30,92",
"    </a>",
"    ]. However, with each local recurrence, there is a greater need for more complex en bloc resections, and tumor resectability dramatically diminishes with each reoperation. In one series, resectability rates were 80 percent for primary tumors, compared to 57, 33, and 14 percent for first, second, and third recurrences, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term tumor control and survival rates are poor, particularly for high-grade histologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/5,34,93-95\">",
"     5,34,93-95",
"    </a>",
"    ], rapidly progressing tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/96\">",
"     96",
"    </a>",
"    ], those with short recurrence-free intervals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/92\">",
"     92",
"    </a>",
"    ], and those resected with a positive margin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30,92,93\">",
"     30,92,93",
"    </a>",
"    ]. However, even patients who undergo complete resection have high local recurrence rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30,93\">",
"     30,93",
"    </a>",
"    ]. In a report of 24 patients who underwent complete resection of a locally recurrent retroperitoneal sarcoma at the University of Heidelberg between 1988 and 2002, 20 recurred locally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Surgical debulking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether there is benefit from palliative \"debulking\" surgery in patients who have unresectable, locally recurrent disease at the time of exploration is unclear. In patients with a primary or recurrent retroperitoneal STS that cannot be completely resected, surgical debulking is not associated with an improvement in long-term survival. Moreover, although short-term palliation of many symptoms associated with intraabdominal sarcomas may be achieved, perioperative morbidity and mortality rates are high (29 and 12 percent in one series of 112 patients undergoing palliative surgery at Memorial Sloan Kettering [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/97\">",
"     97",
"    </a>",
"    ]), and the opportunity to achieve sustained relief of gastrointestinal obstructive symptoms is limited. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Role of debulking surgery'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    On the other hand, repeated debulking surgery may be a reasonable option for some patients with low-grade liposarcomas, although complete resection is the preferred intent of surgery, if feasible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Adjunctive radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who have not previously received radiation therapy, management of a local recurrence should be the same as for a de novo tumor. Preoperative RT is preferred for the reasons outlined above. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Preoperative RT'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The addition of IORT may improve the local control rate in patients undergoing an operation for recurrent retroperitoneal sarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/78,98\">",
"     78,98",
"    </a>",
"    ]. In one series of 32 such patients, 20 of whom had locally recurrent disease, patients received maximal tumor resection, IORT, and postoperative RT where feasible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/78\">",
"     78",
"    </a>",
"    ]. The local control rate was 54 percent for patients with recurrent disease. The most common posttreatment complications were gastrointestinal obstruction (18 percent) and fistula formation (9 percent); wound complications occurred in only 3 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Chemotherapy with regional hyperthermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A possible benefit for regional hyperthermia in conjunction with preoperative chemotherapy was suggested in the EORTC trial 62961, which included patients with locally recurrent retroperitoneal sarcoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/74\">",
"     74",
"    </a>",
"    ]. These data are discussed in detail above. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Systemic chemotherapy with regional hyperthermia'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     CHARGED PARTICLE IRRADIATION FOR UNRESECTABLE DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some unresectable retroperitoneal sarcomas may be controlled with the use of high-dose charged-particle irradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/23/33146/abstract/99\">",
"     99",
"    </a>",
"    ]. This may require the surgical placement of a spacer to displace bowel away from the tumor to avoid bowel injury by high dose radiation. Availability of this technology is limited to a few specialized centers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     POSTTREATMENT FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials evaluating different surveillance strategies following completion of treatment for a retroperitoneal sarcoma. The following consensus-based guidelines are available from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN",
"    </a>",
"    :",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For completely resected retroperitoneal sarcomas: physical examination with",
"      <span class=\"nowrap\">",
"       abdominal/pelvic",
"      </span>",
"      imaging every three to six months for two to three years, and then annually;",
"     </li>",
"     <li>",
"      For retroperitoneal sarcomas resected with positive margins: physical examination with",
"      <span class=\"nowrap\">",
"       abdominal/pelvic",
"      </span>",
"      imaging every three to six months for two to three years, then every six months for the next two years, and then annually;",
"     </li>",
"     <li>",
"      In either case, no specific recommendation is made for periodic chest imaging. However, given the higher rate of lung metastases with retroperitoneal and visceral leiomyosarcomas (as compared to other histologies), we recommend imaging of the chest in addition to the abdomen and pelvis on a regular schedule in these cases. Some clinicians routinely perform surveillance chest imaging for all patients with large, high-grade tumors, regardless of histology.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given that late recurrences are not uncommon with retroperitoneal sarcomas, long-term follow-up to at least 10 years is mandatory. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Outcomes and prognostic factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Retroperitoneal soft tissue sarcomas (STS) constitute between 10 and 15 percent of all STS. The most common histologic types are liposarcoma and leiomyosarcoma. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy, histology and differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Retroperitoneal sarcomas typically produce few symptoms until they are large enough to compress or invade surrounding structures; most commonly, they are discovered in asymptomatic patients as an incidental abdominal mass. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The preferred diagnostic work-up is CT scan of the abdomen and pelvis to evaluate the primary site, and chest CT to rule out metastatic disease to the lungs. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Radiographic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Initial treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All patients with retroperitoneal sarcoma should be managed by a multidisciplinary team with expertise in soft tissue sarcoma. The multidisciplinary team approach by dedicated subspecialists optimizes treatment planning, minimizes the duplication of diagnostic studies, reduces the time to implementation of the definitive therapeutic protocol, and improves clinical outcomes.",
"     </li>",
"     <li>",
"      Complete resection is the only potentially curative treatment. However, because of the large size and anatomic complexity of the retroperitoneum, microscopically positive resection margins are common, and locoregional recurrence is frequent. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Surgical resection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adjunctive radiation therapy (RT) reduces the risk of local recurrence but does not improve overall survival. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Adjunctive RT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with a high-grade or intermediate-grade retroperitoneal soft tissue sarcoma, and for selected patients with a low-grade retroperitoneal sarcoma (eg, one that is extremely large, or appears initially unresectable or borderline resectable), we suggest preoperative RT rather than initial surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Preoperative RT'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      In this setting, we suggest RT alone rather than chemoradiotherapy, unless the patient is being treated in the context of a clinical trial (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Preoperative chemoradiotherapy'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For patients undergoing nonsurgical initial treatment, a preoperative biopsy is mandatory. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Need for biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with either",
"      <span class=\"nowrap\">",
"       intermediate/high-grade",
"      </span>",
"      histology or positive resection margins who have undergone surgical resection without preoperative RT, postoperative RT is a reasonable option, if this can be done within the tolerance of the adjacent normal tissues. The main benefit is a reduction in the risk of a disease recurrence. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Adjuvant RT'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For patients who are left with gross residual disease, we administer a postoperative, small-field supplemental boost dose or intraoperative radiation for an additional dose of 10 to 15 Gy to areas of grossly evident disease. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Role of intraoperative RT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Consensus-based guidelines for posttreatment surveillance are available from the",
"      <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"       NCCN",
"      </a>",
"      . Given the risk for late recurrence, long-term follow-up beyond five years is warranted. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Posttreatment follow-up'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Local recurrence",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with a locally recurrent, potentially resectable retroperitoneal STS, surgical resection should be attempted. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Management of local recurrence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who did not receive RT as part of initial therapy for their sarcoma, we suggest adjunctive RT (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For most patients, we prefer preoperative RT to postoperative RT. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Adjunctive radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with an unresectable disease recurrence, the role of surgical debulking is unclear. Repeated debulking surgery may be a reasonable option for some patients with low-grade liposarcomas, although complete resection is preferred, if feasible. For other patients, debulking surgery does not improve long-term survival, and it should not be attempted. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Surgical debulking'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Regional hyperthermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not used in the US, preoperative regional hyperthermia with systemic chemotherapy is another therapeutic option for high-risk primary or locally recurrent tumors in parts of the world where it is available (mainly Germany). Whether this approach is superior to surgery with or without radiotherapy or chemoradiotherapy will require a randomized trial. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Systemic chemotherapy with regional hyperthermia'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/1\">",
"      Lawrence W Jr, Donegan WL, Natarajan N, et al. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg 1987; 205:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/2\">",
"      Raut CP, Pisters PW. Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol 2006; 94:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/3\">",
"      Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 2006; 106:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/4\">",
"      Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/5\">",
"      Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100:2448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/6\">",
"      Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/7\">",
"      Liles JS, Tzeng CW, Short JJ, et al. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg 2009; 46:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/8\">",
"      Pham TH, Iqbal CW, Zarroug AE, et al. Retroperitoneal sarcomas in children: outcomes from an institution. J Pediatr Surg 2007; 42:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/9\">",
"      Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am J Surg Pathol 2007; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/10\">",
"      Perez EA, Gutierrez JC, Moffat FL Jr, et al. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol 2007; 14:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/11\">",
"      Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 2009; 250:970.",
"     </a>",
"    </li>",
"    <li>",
"     Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of tumours: Pathology and Genetics of tumours of soft tissue and bone, IARC Press, Lyon 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/13\">",
"      Chung L, Lau SK, Jiang Z, et al. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Am J Surg Pathol 2009; 33:1594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/14\">",
"      Hostein I, Pelmus M, Aurias A, et al. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 2004; 202:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/15\">",
"      Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 2008; 15:2739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/16\">",
"      Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/17\">",
"      Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg 1991; 214:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/18\">",
"      Kilkenny JW 3rd, Bland KI, Copeland EM 3rd. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg 1996; 182:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/19\">",
"      Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of \"dedifferentiation\". Am J Surg Pathol 1992; 16:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/20\">",
"      Strauss G, Christensen L, Zapf J. Tumour-induced hypoglycaemia due to 'big' IGF-II. J Intern Med 1994; 236:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/21\">",
"      Alldinger I, Yang Q, Pilarsky C, et al. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. Anticancer Res 2006; 26:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/22\">",
"      Lahat G, Madewell JE, Anaya DA, et al. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer 2009; 115:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/23\">",
"      Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990; 212:51.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer). Cancer Staging Manual, 7th edition, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.291.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/25\">",
"      Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/26\">",
"      Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997; 15:2832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/27\">",
"      van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004; 11:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/28\">",
"      Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg 2004; 239:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/29\">",
"      Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994; 29:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/30\">",
"      Lehnert T, Cardona S, Hinz U, et al. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival. Eur J Surg Oncol 2009; 35:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/31\">",
"      Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol 2008; 98:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/32\">",
"      Pierie JP, Betensky RA, Choudry U, et al. Outcomes in a series of 103 retroperitoneal sarcomas. Eur J Surg Oncol 2006; 32:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/33\">",
"      Avanc&egrave;s C, Mottet N, Mahatmat A, et al. Prognostic factors for first recurrence in patients with retroperitoneal sarcoma. Urol Oncol 2006; 24:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/34\">",
"      van Dalen T, Hoekstra HJ, van Geel AN, et al. Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol 2001; 27:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/35\">",
"      Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer 2005; 104:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/36\">",
"      Russo P, Kim Y, Ravindran S, et al. Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol 1997; 4:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/37\">",
"      Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009; 27:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/38\">",
"      Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/39\">",
"      Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol 2010; 17:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/40\">",
"      Schwarzbach MH, Hormann Y, Hinz U, et al. Clinical results of surgery for retroperitoneal sarcoma with major blood vessel involvement. J Vasc Surg 2006; 44:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/41\">",
"      Daylami R, Amiri A, Goldsmith B, et al. Inferior vena cava leiomyosarcoma: is reconstruction necessary after resection? J Am Coll Surg 2010; 210:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/42\">",
"      Hollenbeck ST, Grobmyer SR, Kent KC, Brennan MF. Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg 2003; 197:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/43\">",
"      Fiore M, Colombo C, Locati P, et al. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol 2012; 19:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/44\">",
"      Shibata D, Lewis JJ, Leung DH, Brennan MF. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? J Am Coll Surg 2001; 193:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/45\">",
"      Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002; 52:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/46\">",
"      Willett CG, Suit HD, Tepper JE, et al. Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer 1991; 68:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/47\">",
"      Gunderson LL, Nagorney DM, McIlrath DC, et al. External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1993; 25:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/48\">",
"      Krempien R, Roeder F, Oertel S, et al. Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2006; 65:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/49\">",
"      Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2001; 50:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/50\">",
"      Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993; 128:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/51\">",
"      Stojadinovic A, Leung DH, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002; 235:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/52\">",
"      Zagars GK, Ballo MT, Pisters PW, et al. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer 2003; 97:2544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/53\">",
"      Delaney TF, Kepka L, Goldberg SI, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 2007; 67:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/54\">",
"      van Doorn RC, Gallee MP, Hart AA, et al. Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer 1994; 73:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/55\">",
"      Jones JJ, Catton CN, O'Sullivan B, et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 2002; 9:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/56\">",
"      Choi AH, Barnholtz-Sloan JS, Kim JA. Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol 2012; 23:2449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/57\">",
"      Nielsen OS, O'Sullivan B. Retroperitoneal soft tissue sarcomas: a treatment challenge and a call for randomized trials. Radiother Oncol 2002; 65:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/58\">",
"      Tzeng CW, Fiveash JB, Popple RA, et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006; 107:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/59\">",
"      Ito H, Hornick JL, Bertagnolli MM, et al. Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol 2007; 14:3534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/60\">",
"      Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 2007; 67:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/61\">",
"      Zlotecki RA, Katz TS, Morris CG, et al. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 2005; 28:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/62\">",
"      Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol 2003; 21:3092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/63\">",
"      Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006; 13:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/64\">",
"      Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/65\">",
"      Bossi A, De Wever I, Van Limbergen E, Vanstraelen B. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int J Radiat Oncol Biol Phys 2007; 67:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/66\">",
"      Koshy M, Landry JC, Lawson JD, et al. Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction. Sarcoma 2003; 7:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/67\">",
"      Musat E, Kantor G, Caron J, et al. [Comparison of intensity-modulated postoperative radiotherapy with conventional postoperative conformal radiotherapy for retroperitoneal sarcoma]. Cancer Radiother 2004; 8:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/68\">",
"      Eilber F, Eckardt J, Rosen G, et al. Preoperative therapy for soft tissue sarcoma. Hematol Oncol Clin North Am 1995; 9:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/69\">",
"      Meric F, Hess KR, Varma DG, et al. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer 2002; 95:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/70\">",
"      Wendtner CM, Abdel-Rahman S, Krych M, et al. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2002; 20:3156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/71\">",
"      Meric F, Milas M, Hunt KK, et al. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol 2000; 18:3378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/72\">",
"      Donahue TR, Kattan MW, Nelson SD, et al. Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram. Cancer 2010; 116:3883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/73\">",
"      Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer 2005; 41:2853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/74\">",
"      Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010; 11:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/75\">",
"      Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/76\">",
"      Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol 2000; 18:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/77\">",
"      Karakousis CP, Velez AF, Gerstenbluth R, Driscoll DL. Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol 1996; 3:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/78\">",
"      Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000; 47:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/79\">",
"      Paryani NN, Zlotecki RA, Swanson EL, et al. Multimodality local therapy for retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys 2012; 82:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/80\">",
"      Jenkins MP, Alvaranga JC, Thomas JM. The management of retroperitoneal soft tissue sarcomas. Eur J Cancer 1996; 32A:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/81\">",
"      Herman K, Gruchaa A, Niezabitowski A, et al. Prognostic factors in retroperitoneal sarcomas: ploidy of DNA as a predictor of clinical outcome. J Surg Oncol 1999; 71:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/82\">",
"      Erzen D, Sencar M, Novak J. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana. J Surg Oncol 2005; 91:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/83\">",
"      Pacelli F, Tortorelli AP, Rosa F, et al. Retroperitoneal soft tissue sarcoma: prognostic factors and therapeutic approaches. Tumori 2008; 94:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/84\">",
"      Ardoino I, Miceli R, Berselli M, et al. Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer 2010; 116:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/85\">",
"      Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol 2009; 16:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/86\">",
"      Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 2010; 21:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/87\">",
"      Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer 2008; 113:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/88\">",
"      Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/89\">",
"      Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006; 244:381.",
"     </a>",
"    </li>",
"    <li>",
"     Postoperative sarcoma nomogram file://nomograms.mskcc.org/Sarcoma/PostSurgery.aspx (Accessed on January 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/91\">",
"      ESMO / European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 Suppl 7:vii92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/92\">",
"      Wang YN, Zhu WQ, Shen ZZ, et al. Treatment of locally recurrent soft tissue sarcomas of the retroperitoneum: report of 30 cases. J Surg Oncol 1994; 56:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/93\">",
"      Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg 2003; 138:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/94\">",
"      Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/95\">",
"      Chiappa A, Zbar AP, Bertani E, et al. Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival. J Surg Oncol 2006; 93:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/96\">",
"      Park JO, Qin LX, Prete FP, et al. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Ann Surg 2009; 250:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/97\">",
"      Yeh JJ, Singer S, Brennan MF, Jaques DP. Effectiveness of palliative procedures for intra-abdominal sarcomas. Ann Surg Oncol 2005; 12:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/98\">",
"      Dziewirski W, Rutkowski P, Nowecki ZI, et al. Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas. Ann Surg Oncol 2006; 13:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/23/33146/abstract/99\">",
"      Serizawa I, Kagei K, Kamada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2009; 75:1105.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7736 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-A590A08E48-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33146=[""].join("\n");
var outline_f32_23_33146=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY, HISTOLOGY AND DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Histologic types",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Liposarcomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Leiomyosarcomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSTIC EVALUATION AND STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radiographic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Need for biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Criteria for unresectability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Surgical resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Role of debulking surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Role of intraoperative RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Management of microscopically positive margins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Adjunctive RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Adjuvant RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Preoperative RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Preoperative IMRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Preoperative chemoradiotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Preoperative chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Systemic chemotherapy with regional hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Outcomes and prognostic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Summary and recommendations from expert groups",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      MANAGEMENT OF LOCAL RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Surgical debulking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Adjunctive radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Chemotherapy with regional hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      CHARGED PARTICLE IRRADIATION FOR UNRESECTABLE DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      POSTTREATMENT FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Initial treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Local recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Regional hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/7736\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/7736|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/13/23773\" title=\"table 1\">",
"      2010 TNM staging STS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/32/8715\" title=\"table 2\">",
"      Staging system retroperit sarc",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/11/14521?source=related_link\">",
"      Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/3/28729?source=related_link\">",
"      Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/51/6970?source=related_link\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34136?source=related_link\">",
"      Clinical manifestations and diagnosis of retroperitoneal fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41720?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/568?source=related_link\">",
"      Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=related_link\">",
"      Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/56/37769?source=related_link\">",
"      Clinical presentation, staging, and prognostic factors of the Ewing sarcoma family of tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/11/30906?source=related_link\">",
"      Desmoid tumors: Epidemiology, risk factors, molecular pathogenesis, clinical presentation, diagnosis, and local therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35386?source=related_link\">",
"      Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10058?source=related_link\">",
"      Extragonadal germ cell tumors involving the mediastinum and retroperitoneum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/50/34602?source=related_link\">",
"      Head and neck sarcomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38650?source=related_link\">",
"      Local treatment for primary soft tissue sarcoma of the extremities and chest wall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11461?source=related_link\">",
"      Nonislet cell tumor hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18327?source=related_link\">",
"      Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/40/44680?source=related_link\">",
"      Surgical treatment and other localized therapy for metastatic soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/11/41146?source=related_link\">",
"      Systemic treatment of metastatic soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27354?source=related_link\">",
"      Treatment of locally recurrent and unresectable, locally advanced soft tissue sarcoma of the extremities",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_23_33147="Defin statin-related issues";
var content_f32_23_33147=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Proposed definitions for statin-related issues from muscle expert panel",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Myopathy",
"      </td>",
"      <td class=\"sublist_other_start\">",
"       General term for all statin-related muscle problems",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Symptomatic myopathy",
"      </td>",
"      <td class=\"sublist_other\">",
"       Signs and symptoms referable to skeletal muscle, including myalgias (muscle pain), weakness (subjective or objective), and cramps",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Asymptomatic myopathy",
"      </td>",
"      <td class=\"sublist_other\">",
"       CK elevations without objective weakness or subjective complaints",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clinically important rhabdomyolysis",
"      </td>",
"      <td>",
"       Any evidence of muscle cell destruction or enzyme leakage felt to be causally related to a change in renal function",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\" colspan=\"2\">",
"       Levels of CK elevation (whether asymptomatic myopathy or clinically important rhabdomyolysis)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Mild CK increase",
"      </td>",
"      <td class=\"sublist_other\">",
"       CK above the ULN but &lt;10 times ULN",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Moderate CK increase",
"      </td>",
"      <td class=\"sublist_other\">",
"       CK &ge;10 times ULN but &lt;50 times ULN",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Marked CK increase",
"      </td>",
"      <td class=\"sublist_other\">",
"       CK &ge;50 times ULN",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CK: creatine kinase; ULN: upper limit of normal.",
"    </div>",
"    <div class=\"reference\">",
"     Source: Thompson, PD, Clarkson, PM, Rosenson, RS. An Assessment of Statin Safety by Muscle Experts. Am J Cardiol 2006; 97:69C.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33147=[""].join("\n");
var outline_f32_23_33147=null;
var title_f32_23_33148="Menzies method";
var content_f32_23_33148=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F66385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F66385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Menzies method",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Criteria",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <p>",
"         <strong>",
"          Negative features",
"         </strong>",
"        </p>",
"        <p>",
"         Neither can be present in melanoma",
"        </p>",
"       </td>",
"       <td>",
"        Symmetrical pigmentation pattern",
"       </td>",
"       <td>",
"        Symmetric pigment pattern across all axes.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Presence of only a single color",
"       </td>",
"       <td>",
"        Presence of only 1 color:",
"        <ol>",
"         <li>",
"          Tan",
"         </li>",
"         <li>",
"          Dark brown",
"         </li>",
"         <li>",
"          Black",
"         </li>",
"         <li>",
"          Gray",
"         </li>",
"         <li>",
"          Blue",
"         </li>",
"         <li>",
"          Red",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"9\">",
"        <p>",
"         <strong>",
"          Positive features",
"         </strong>",
"        </p>",
"        <p>",
"         At least one feature has to be present to consider the diagnosis of melanoma",
"        </p>",
"       </td>",
"       <td>",
"        Multiple (5-6) colors",
"       </td>",
"       <td>",
"        Presence of 5 or 6 of the above colors.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blue-white veil",
"       </td>",
"       <td>",
"        Irregular and confluent blue pigmentation with an overlying white \"ground glass\" film, not associated with red-blue lacunae.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple brown dots",
"       </td>",
"       <td>",
"        Aggregations of dark brown dots, usually within the body of the lesion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple blue/gray dots",
"       </td>",
"       <td>",
"        Diffuse, partly aggregated dots, \"pepper-like\" in appearance.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peripheral black dots or globules",
"       </td>",
"       <td>",
"        Black dots or globules at or near the edge of the lesion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Broadened network",
"       </td>",
"       <td>",
"        Pigment network with areas of thick grids.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudopods",
"       </td>",
"       <td>",
"        Finger-like projections with small knobs at their tips, which are directly connected to the tumor body or the pigment network.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radial streaming",
"       </td>",
"       <td>",
"        Radial and asymmetric linear extensions at the edge of the lesion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scar-like depigmentation",
"       </td>",
"       <td>",
"        White, irregular area of depigmentation.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Menzies SW, Ingvar C, Crotty KA, McCarthy WH. Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol 1996; 132:1178.",
"       </li>",
"       <li>",
"        Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55.",
"       </li>",
"      </ol>",
"      <br>",
"       Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33148=[""].join("\n");
var outline_f32_23_33148=null;
var title_f32_23_33149="Hypothalamic set-point vs body temperature";
var content_f32_23_33149=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Relationship of hypothalamic set-point to body temperature",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 344px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Euthermia: hypothalamic set-point is normal, and body temperature approximates set-point and is also normal.",
"    <br>",
"     Fever: hypothalamic set-point is elevated, and body temperature follows set-point and is also elevated.",
"     <br>",
"      Heat illness: hypothalamic set-point is normal, and body temperature is elevated despite normal set-point.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33149=[""].join("\n");
var outline_f32_23_33149=null;
var title_f32_23_33150="Cri du chat syndrome";
var content_f32_23_33150=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F66560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F66560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cri du chat syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cri du chat syndrome is due to a large deletion of the terminal short arm of chromosome 5. The size of the deletion may be different in each patient, but it always encompasses chromosomal bands 5p15.2 and 5p15.3. The&nbsp;representation of chromosome 5 (on the left) indicates the deletion breakpoint that was identified in one patient. The shortened p-arm of a chromosome 5, stained by GTG (G-banding with trypsin and Giemsa)-banding, is shown on the right. For comparison, a chromosome 5 from a normal individual is placed in the middle. The boxed fragment indicates the extent of the deletion in the affected chromosome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Athena Cherry, Stanford Hospital and Clinics",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33150=[""].join("\n");
var outline_f32_23_33150=null;
var title_f32_23_33151="Pressure volume exercise";
var content_f32_23_33151=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pressure volume exercise",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 266px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_23_33151=[""].join("\n");
var outline_f32_23_33151=null;
